{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T01:21:57Z","timestamp":1795224117999,"version":"4.10.3"},"reference-count":209,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T00:00:00Z","timestamp":1665619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T00:00:00Z","timestamp":1665619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004434","name":"Universit\u00e0 degli Studi di Firenze","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004434","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Metastasis Rev"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Tumour vascularisation is vital for cancer sustainment representing not only the main source of nutrients and oxygen supply but also an escape route for single or clustered cancer cells that, once detached from the primary mass, enter the blood circulation and disseminate to distant organs. Among the mechanisms identified to contribute to tumour vascularisation, vasculogenic mimicry (VM) is gaining increasing interest in the scientific community representing an intriguing target for cancer treatment. VM indeed associates with highly aggressive tumour phenotypes and strongly impairs patient outcomes. Differently from vessels of healthy tissues, tumour vasculature is extremely heterogeneous and tortuous, impeding efficient chemotherapy delivery, and at the meantime hyperpermeable and thus extremely accessible to metastasising cancer cells. Moreover, tumour vessel disorganisation creates a self-reinforcing vicious circle fuelling cancer malignancy and progression. Because of the inefficient oxygen delivery and metabolic waste removal from tumour vessels, many cells within the tumour mass indeed experience hypoxia and acidosis, now considered hallmarks of cancer. Being strong inducers of vascularisation, therapy resistance, inflammation and metastasis, hypoxia and acidosis create a permissive microenvironment for cancer progression and dissemination. Along with these considerations, we decided to focus our attention on the relationship between hypoxia\/acidosis and VM. Indeed, besides tumour angiogenesis, VM is strongly influenced by both hypoxia and acidosis, which could potentiate each other and fuel this vicious circle. Thus, targeting hypoxia and acidosis may represent a potential target to treat VM to impair tumour perfusion and cancer cell sustainment.<\/jats:p>","DOI":"10.1007\/s10555-022-10067-x","type":"journal-article","created":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T19:03:44Z","timestamp":1665601424000},"page":"935-951","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Physicochemical aspects of the tumour microenvironment as drivers of vasculogenic mimicry"],"prefix":"10.1007","volume":"41","author":[{"given":"Elena","family":"Andreucci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6459-0458","authenticated-orcid":false,"given":"Silvia","family":"Peppicelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Ruzzolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Bianchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lido","family":"Calorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,13]]},"reference":[{"issue":"3421","key":"10067_CR1","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0140-6736(00)49915-0","volume":"133","author":"S Paget","year":"1889","unstructured":"Paget, S. (1889). The distribution of secondary growths in cancer of the breast. The Lancet, 133(3421), 571\u2013573. https:\/\/doi.org\/10.1016\/S0140-6736(00)49915-0","journal-title":"The Lancet"},{"issue":"2","key":"10067_CR2","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/nrc2067","volume":"7","author":"A Albini","year":"2007","unstructured":"Albini, A., & Sporn, M. B. (2007). The tumour microenvironment as a target for chemoprevention. Nature Reviews Cancer, 7(2), 139\u2013147. https:\/\/doi.org\/10.1038\/nrc2067","journal-title":"Nature Reviews Cancer"},{"issue":"5","key":"10067_CR3","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer: The next generation. Cell, 144(5), 646\u2013674. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013","journal-title":"Cell"},{"issue":"12","key":"10067_CR4","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1007\/s00109-017-1590-9","volume":"95","author":"E Andreucci","year":"2017","unstructured":"Andreucci, E., Peppicelli, S., Carta, F., Brisotto, G., Biscontin, E., Ruzzolini, J., & Calorini, L. (2017). Carbonic anhydrase IX inhibition affects viability of cancer cells adapted to extracellular acidosis. Journal of Molecular Medicine (Berlin, Germany), 95(12), 1341\u20131353. https:\/\/doi.org\/10.1007\/s00109-017-1590-9","journal-title":"Journal of Molecular Medicine (Berlin, Germany)"},{"issue":"3","key":"10067_CR5","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.semradonc.2004.04.008","volume":"14","author":"P Vaupel","year":"2004","unstructured":"Vaupel, P. (2004). Tumor microenvironmental physiology and its implications for radiation oncology. Seminars in Radiation Oncology, 14(3), 198\u2013206. https:\/\/doi.org\/10.1016\/j.semradonc.2004.04.008","journal-title":"Seminars in Radiation Oncology"},{"issue":"6","key":"10067_CR6","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1002\/nbm.1644","volume":"24","author":"AI Hashim","year":"2011","unstructured":"Hashim, A. I., Zhang, X., Wojtkowiak, J. W., Martinez, G. V., & Gillies, R. J. (2011). Imaging pH and metastasis. NMR in Biomedicine, 24(6), 582\u2013591. https:\/\/doi.org\/10.1002\/nbm.1644","journal-title":"NMR in Biomedicine"},{"issue":"3","key":"10067_CR7","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/0165-1161(95)90067-5","volume":"334","author":"T Morita","year":"1995","unstructured":"Morita, T. (1995). Low pH leads to sister-chromatid exchanges and chromosomal aberrations, and its clastogenicity is S-dependent. Mutation Research\/Environmental Mutagenesis and Related Subjects, 334(3), 301\u2013308. https:\/\/doi.org\/10.1016\/0165-1161(95)90067-5","journal-title":"Mutation Research\/Environmental Mutagenesis and Related Subjects"},{"key":"10067_CR8","doi-asserted-by":"publisher","first-page":"626229","DOI":"10.3389\/fcell.2021.626229","volume":"9","author":"M Tang","year":"2021","unstructured":"Tang, M., Bolderson, E., O\u2019Byrne, K. J., & Richard, D. J. (2021). Tumor hypoxia drives genomic instability. Frontiers in Cell and Developmental Biology, 9, 626229. https:\/\/doi.org\/10.3389\/fcell.2021.626229","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"7","key":"10067_CR9","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1128\/MCB.24.7.2875-2889.2004","volume":"24","author":"JT Erler","year":"2004","unstructured":"Erler, J. T., Cawthorne, C. J., Williams, K. J., Koritzinsky, M., Wouters, B. G., Wilson, C., & Dive, C. (2004). Hypoxia-mediated down-regulation of Bid and Bax in tumors occurs via hypoxia-inducible factor 1-dependent and -independent mechanisms and contributes to drug resistance. Molecular and Cellular Biology, 24(7), 2875\u20132889. https:\/\/doi.org\/10.1128\/MCB.24.7.2875-2889.2004","journal-title":"Molecular and Cellular Biology"},{"issue":"4","key":"10067_CR10","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10585-014-9637-6","volume":"31","author":"S Peppicelli","year":"2014","unstructured":"Peppicelli, S., Bianchini, F., Torre, E., & Calorini, L. (2014). Contribution of acidic melanoma cells undergoing epithelial-to-mesenchymal transition to aggressiveness of non-acidic melanoma cells. Clinical & Experimental Metastasis, 31(4), 423\u2013433. https:\/\/doi.org\/10.1007\/s10585-014-9637-6","journal-title":"Clinical & Experimental Metastasis"},{"issue":"2","key":"10067_CR11","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.semradonc.2008.12.002","volume":"19","author":"RP Hill","year":"2009","unstructured":"Hill, R. P., Marie-Egyptienne, D. T., & Hedley, D. W. (2009). Cancer stem cells, hypoxia and metastasis. Seminars in Radiation Oncology, 19(2), 106\u2013111. https:\/\/doi.org\/10.1016\/j.semradonc.2008.12.002","journal-title":"Seminars in Radiation Oncology"},{"issue":"1","key":"10067_CR12","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1146\/annurev-physiol-021119-034627","volume":"82","author":"E Boedtkjer","year":"2020","unstructured":"Boedtkjer, E., & Pedersen, S. F. (2020). The acidic tumor microenvironment as a driver of cancer. Annual Review of Physiology, 82(1), 103\u2013126. https:\/\/doi.org\/10.1146\/annurev-physiol-021119-034627","journal-title":"Annual Review of Physiology"},{"issue":"2","key":"10067_CR13","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.stem.2010.07.007","volume":"7","author":"A Mohyeldin","year":"2010","unstructured":"Mohyeldin, A., Garz\u00f3n-Muvdi, T., & Qui\u00f1ones-Hinojosa, A. (2010). Oxygen in stem cell biology: A critical component of the stem cell niche. Cell Stem Cell, 7(2), 150\u2013161. https:\/\/doi.org\/10.1016\/j.stem.2010.07.007","journal-title":"Cell Stem Cell"},{"issue":"10","key":"10067_CR14","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1007\/s00109-020-01959-y","volume":"98","author":"E Andreucci","year":"2020","unstructured":"Andreucci, E., Peppicelli, S., Ruzzolini, J., Bianchini, F., Biagioni, A., Papucci, L., & Calorini, L. (2020). The acidic tumor microenvironment drives a stem-like phenotype in melanoma cells. Journal of Molecular Medicine, 98(10), 1431\u20131446. https:\/\/doi.org\/10.1007\/s00109-020-01959-y","journal-title":"Journal of Molecular Medicine"},{"key":"10067_CR15","doi-asserted-by":"publisher","unstructured":"Zhang, T., Suo, C., Zheng, C., & Zhang, H. (2019). Hypoxia and metabolism in metastasis. In D. M. Gilkes (Ed.), Hypoxia and cancer metastasis, 1136, 87\u201395. Cham: Springer International Publishing. https:\/\/doi.org\/10.1007\/978-3-030-12734-3_6","DOI":"10.1007\/978-3-030-12734-3_6"},{"issue":"1","key":"10067_CR16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/2049-3002-1-23","volume":"1","author":"G LaMonte","year":"2013","unstructured":"LaMonte, G., Tang, X., Chen, J.L.-Y., Wu, J., Ding, C.-K.C., Keenan, M. M., & Chi, J.-T. (2013). Acidosis induces reprogramming of cellular metabolism to mitigate oxidative stress. Cancer & Metabolism, 1(1), 23. https:\/\/doi.org\/10.1186\/2049-3002-1-23","journal-title":"Cancer & Metabolism"},{"key":"10067_CR17","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.3389\/fonc.2019.01419","volume":"9","author":"ON Hern\u00e1ndez de la Cruz","year":"2019","unstructured":"Hern\u00e1ndez de la Cruz, O. N., L\u00f3pez-Gonz\u00e1lez, J. S., Garc\u00eda-V\u00e1zquez, R., Salinas-Vera, Y. M., Mu\u00f1iz-Lino, M. A., Aguilar-Cazares, D., & Carlos-Reyes, \u00c1. (2019). Regulation networks driving vasculogenic mimicry in solid tumors. Frontiers in Oncology, 9, 1419. https:\/\/doi.org\/10.3389\/fonc.2019.01419","journal-title":"Frontiers in Oncology"},{"issue":"4","key":"10067_CR18","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/ijc.30067","volume":"139","author":"S Krishna Priya","year":"2016","unstructured":"Krishna Priya, S., Nagare, R. P., Sneha, V. S., Sidhanth, C., Bindhya, S., Manasa, P., & Ganesan, T. S. (2016). Tumour angiogenesis\u2013origin of blood vessels: Tumour angiogenesis. International Journal of Cancer, 139(4), 729\u2013735. https:\/\/doi.org\/10.1002\/ijc.30067","journal-title":"International Journal of Cancer"},{"issue":"14","key":"10067_CR19","doi-asserted-by":"publisher","first-page":"7698","DOI":"10.3390\/ijms22147698","volume":"22","author":"S Peri","year":"2021","unstructured":"Peri, S., Biagioni, A., Versienti, G., Andreucci, E., Staderini, F., Barbato, G., & Magnelli, L. (2021). Enhanced vasculogenic capacity induced by 5-fluorouracil chemoresistance in a gastric cancer cell line. International Journal of Molecular Sciences, 22(14), 7698. https:\/\/doi.org\/10.3390\/ijms22147698","journal-title":"International Journal of Molecular Sciences"},{"issue":"3","key":"10067_CR20","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S0002-9440(10)65173-5","volume":"155","author":"AJ Maniotis","year":"1999","unstructured":"Maniotis, A. J., Folberg, R., Hess, A., Seftor, E. A., Gardner, L. M. G., Pe\u2019er, J., & Hendrix, M. J. C. (1999). Vascular channel formation by human melanoma cells in vivo and in vitro: Vasculogenic mimicry. The American Journal of Pathology, 155(3), 739\u2013752. https:\/\/doi.org\/10.1016\/S0002-9440(10)65173-5","journal-title":"The American Journal of Pathology"},{"issue":"3","key":"10067_CR21","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S0002-9440(10)65173-5","volume":"155","author":"AJ Maniotis","year":"1999","unstructured":"Maniotis, A. J., Folberg, R., Hess, A., Seftor, E. A., Gardner, L. M., Pe\u2019er, J., & Hendrix, M. J. C. (1999). Vascular channel formation by human melanoma cells in vivo and in vitro: Vasculogenic mimicry. The American Journal of Pathology, 155(3), 739\u2013752. https:\/\/doi.org\/10.1016\/S0002-9440(10)65173-5","journal-title":"The American Journal of Pathology"},{"issue":"8","key":"10067_CR22","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1158\/0008-5472.CAN-14-1855","volume":"75","author":"CI Schnegg","year":"2015","unstructured":"Schnegg, C. I., Yang, M. H., Ghosh, S. K., & Hsu, M.-Y. (2015). Induction of vasculogenic mimicry overrides VEGF-A silencing and enriches stem-like cancer cells in melanoma. Cancer Research, 75(8), 1682\u20131690. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-1855","journal-title":"Cancer Research"},{"issue":"12","key":"10067_CR23","doi-asserted-by":"publisher","first-page":"101237","DOI":"10.1016\/j.tranon.2021.101237","volume":"14","author":"W He","year":"2021","unstructured":"He, W., Yang, G., Liu, S., Maghsoudloo, M., Shasaltaneh, M. D., Kaboli, P. J., & Wen, Q. (2021). Comparative mRNA\/micro-RNA co-expression network drives melanomagenesis by promoting epithelial\u2013mesenchymal transition and vasculogenic mimicry signaling. Translational Oncology, 14(12), 101237. https:\/\/doi.org\/10.1016\/j.tranon.2021.101237","journal-title":"Translational Oncology"},{"issue":"5","key":"10067_CR24","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/cac2.12026","volume":"40","author":"X Mei","year":"2020","unstructured":"Mei, X., Chen, Y.-S., Zhang, Q.-P., Chen, F.-R., Xi, S.-Y., Long, Y.-K., & Chen, Z.-P. (2020). Association between glioblastoma cell-derived vessels and poor prognosis of the patients. Cancer Communications (London, England), 40(5), 211\u2013221. https:\/\/doi.org\/10.1002\/cac2.12026","journal-title":"Cancer Communications (London, England)"},{"issue":"19","key":"10067_CR25","doi-asserted-by":"publisher","first-page":"10530","DOI":"10.3390\/ijms221910530","volume":"22","author":"C Pagano","year":"2021","unstructured":"Pagano, C., Navarra, G., Pastorino, O., Avilia, G., Coppola, L., Della Monica, R., & Laezza, C. (2021). N6-Isopentenyladenosine hinders the vasculogenic mimicry in human glioblastoma cells through Src-120 catenin pathway modulation and RhoA activity inhibition. International Journal of Molecular Sciences, 22(19), 10530. https:\/\/doi.org\/10.3390\/ijms221910530","journal-title":"International Journal of Molecular Sciences"},{"issue":"10","key":"10067_CR26","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1016\/j.humpath.2014.06.013","volume":"45","author":"K Ren","year":"2014","unstructured":"Ren, K., Yao, N., Wang, G., Tian, L., Ma, J., Shi, X., & Sun, X. (2014). Vasculogenic mimicry: A new prognostic sign of human osteosarcoma. Human Pathology, 45(10), 2120\u20132129. https:\/\/doi.org\/10.1016\/j.humpath.2014.06.013","journal-title":"Human Pathology"},{"issue":"8","key":"10067_CR27","doi-asserted-by":"publisher","first-page":"12473","DOI":"10.1002\/jcb.28514","volume":"120","author":"K Ren","year":"2019","unstructured":"Ren, K., Ni, Y., Li, X., Wang, C., Chang, Q., Li, Y., & Zhou, J. (2019). Expression profiling of long noncoding RNAs associated with vasculogenic mimicry in osteosarcoma. Journal of Cellular Biochemistry, 120(8), 12473\u201312488. https:\/\/doi.org\/10.1002\/jcb.28514","journal-title":"Journal of Cellular Biochemistry"},{"key":"10067_CR28","doi-asserted-by":"publisher","first-page":"619732","DOI":"10.3389\/fphar.2021.619732","volume":"12","author":"Z Chu","year":"2021","unstructured":"Chu, Z., Shi, X., Chen, G., He, X., Qian, Y., Wang, H., & Chen, J. (2021). COE inhibits vasculogenic mimicry by targeting EphA2 in hepatocellular carcinoma, a research based on proteomics analysis. Frontiers in Pharmacology, 12, 619732. https:\/\/doi.org\/10.3389\/fphar.2021.619732","journal-title":"Frontiers in Pharmacology"},{"issue":"9","key":"10067_CR29","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.7150\/jca.40558","volume":"11","author":"X Li","year":"2020","unstructured":"Li, X., Sun, B., Zhao, X., An, J., Zhang, Y., Gu, Q., & Liu, F. (2020). Function of BMP4 in the formation of vasculogenic mimicry in hepatocellular carcinoma. Journal of Cancer, 11(9), 2560\u20132571. https:\/\/doi.org\/10.7150\/jca.40558","journal-title":"Journal of Cancer"},{"key":"10067_CR30","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3389\/fonc.2020.00220","volume":"10","author":"MA Andonegui-Elguera","year":"2020","unstructured":"Andonegui-Elguera, M. A., Alfaro-Mora, Y., C\u00e1ceres-Guti\u00e9rrez, R., Caro-S\u00e1nchez, C. H. S., Herrera, L. A., & D\u00edaz-Ch\u00e1vez, J. (2020). An overview of vasculogenic mimicry in breast cancer. Frontiers in Oncology, 10, 220. https:\/\/doi.org\/10.3389\/fonc.2020.00220","journal-title":"Frontiers in Oncology"},{"issue":"6","key":"10067_CR31","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1002\/ijc.10423","volume":"99","author":"K Shirakawa","year":"2002","unstructured":"Shirakawa, K., Wakasugi, H., Heike, Y., Watanabe, I., Yamada, S., Saito, K., & Konishi, F. (2002). Vasculogenic mimicry and pseudo-comedo formation in breast cancer. International Journal of Cancer, 99(6), 821\u2013828. https:\/\/doi.org\/10.1002\/ijc.10423","journal-title":"International Journal of Cancer"},{"issue":"9","key":"10067_CR32","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1002\/ijc.31958","volume":"144","author":"Y Xia","year":"2019","unstructured":"Xia, Y., Cai, X.-Y., Fan, J.-Q., Zhang, L.-L., Ren, J.-H., Li, Z.-Y., & Wu, G. (2019). The role of sema4D in vasculogenic mimicry formation in non-small cell lung cancer and the underlying mechanisms: Role of sema4D in vasculogenic mimicry formation. International Journal of Cancer, 144(9), 2227\u20132238. https:\/\/doi.org\/10.1002\/ijc.31958","journal-title":"International Journal of Cancer"},{"key":"10067_CR33","doi-asserted-by":"publisher","first-page":"697227","DOI":"10.3389\/fonc.2021.697227","volume":"11","author":"K Niu","year":"2021","unstructured":"Niu, K., Chen, X.-W., Qin, Y., Zhang, L.-P., Liao, R.-X., & Sun, J.-G. (2021). Celecoxib blocks vasculogenic mimicry via an off-target effect to radiosensitize lung cancer cells: An experimental study. Frontiers in Oncology, 11, 697227. https:\/\/doi.org\/10.3389\/fonc.2021.697227","journal-title":"Frontiers in Oncology"},{"issue":"1","key":"10067_CR34","doi-asserted-by":"publisher","first-page":"3414","DOI":"10.1038\/s41598-019-40265-7","volume":"9","author":"HS Kim","year":"2019","unstructured":"Kim, H. S., Won, Y. J., Shim, J. H., Kim, H. J., Kim, J., Hong, H. N., & Kim, B. S. (2019). Morphological characteristics of vasculogenic mimicry and its correlation with EphA2 expression in gastric adenocarcinoma. Scientific Reports, 9(1), 3414. https:\/\/doi.org\/10.1038\/s41598-019-40265-7","journal-title":"Scientific Reports"},{"key":"10067_CR35","doi-asserted-by":"publisher","DOI":"10.1111\/cas.15208","author":"X Song","year":"2021","unstructured":"Song, X., An, Y., Chen, D., Zhang, W., Wu, X., Li, C., & Cao, H. (2021). Microbial metabolite deoxycholic acid promotes vasculogenic mimicry formation in intestinal carcinogenesis. Cancer Science. https:\/\/doi.org\/10.1111\/cas.15208","journal-title":"Cancer Science"},{"issue":"12","key":"10067_CR36","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1007\/DCR.0b013e3181beb4ff","volume":"52","author":"CIM Baeten","year":"2009","unstructured":"Baeten, C. I. M., Hillen, F., Pauwels, P., de Bruine, A. P., & Baeten, C. G. M. I. (2009). Prognostic role of vasculogenic mimicry in colorectal cancer. Diseases of the Colon & Rectum, 52(12), 2028\u20132035. https:\/\/doi.org\/10.1007\/DCR.0b013e3181beb4ff","journal-title":"Diseases of the Colon & Rectum"},{"issue":"7","key":"10067_CR37","doi-asserted-by":"publisher","first-page":"527","DOI":"10.4161\/cbt.19602","volume":"13","author":"R Liu","year":"2012","unstructured":"Liu, R., Yang, K., Meng, C., Zhang, Z., & Xu, Y. (2012). Vasculogenic mimicry is a marker of poor prognosis in prostate cancer. Cancer Biology & Therapy, 13(7), 527\u2013533. https:\/\/doi.org\/10.4161\/cbt.19602","journal-title":"Cancer Biology & Therapy"},{"issue":"9","key":"10067_CR38","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.7150\/jca.14120","volume":"7","author":"H Wang","year":"2016","unstructured":"Wang, H., Lin, H., Pan, J., Mo, C., Zhang, F., Huang, B., & Qiu, S. (2016). Vasculogenic mimicry in prostate cancer: The roles of EphA2 and PI3K. Journal of Cancer, 7(9), 1114\u20131124. https:\/\/doi.org\/10.7150\/jca.14120","journal-title":"Journal of Cancer"},{"issue":"1","key":"10067_CR39","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13045-020-00858-6","volume":"13","author":"Q Luo","year":"2020","unstructured":"Luo, Q., Wang, J., Zhao, W., Peng, Z., Liu, X., Li, B., & Duan, C. (2020). Vasculogenic mimicry in carcinogenesis and clinical applications. Journal of Hematology & Oncology, 13(1), 19. https:\/\/doi.org\/10.1186\/s13045-020-00858-6","journal-title":"Journal of Hematology & Oncology"},{"issue":"2","key":"10067_CR40","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s10456-016-9500-2","volume":"19","author":"JP Yang","year":"2016","unstructured":"Yang, J. P., Liao, Y. D., Mai, D. M., Xie, P., Qiang, Y. Y., Zheng, L. S., & Qian, C. N. (2016). Tumor vasculogenic mimicry predicts poor prognosis in cancer patients: A meta-analysis. Angiogenesis, 19(2), 191\u2013200. https:\/\/doi.org\/10.1007\/s10456-016-9500-2","journal-title":"Angiogenesis"},{"issue":"25","key":"10067_CR41","doi-asserted-by":"publisher","first-page":"6327","DOI":"10.7150\/jca.34171","volume":"10","author":"X Zhang","year":"2019","unstructured":"Zhang, X., Zhang, J., Zhou, H., Fan, G., & Li, Q. (2019). Molecular mechanisms and anticancer therapeutic strategies in vasculogenic mimicry. Journal of Cancer, 10(25), 6327\u20136340. https:\/\/doi.org\/10.7150\/jca.34171","journal-title":"Journal of Cancer"},{"issue":"1","key":"10067_CR42","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12943-017-0631-x","volume":"16","author":"D Delgado-Bellido","year":"2017","unstructured":"Delgado-Bellido, D., Serrano-Saenz, S., Fern\u00e1ndez-Cort\u00e9s, M., & Oliver, F. J. (2017). Vasculogenic mimicry signaling revisited: Focus on non-vascular VE-cadherin. Molecular Cancer, 16(1), 65. https:\/\/doi.org\/10.1186\/s12943-017-0631-x","journal-title":"Molecular Cancer"},{"key":"10067_CR43","doi-asserted-by":"publisher","unstructured":"Cao, Z., Bao, M., Miele, L., Sarkar, F. H., Wang, Z., & Zhou, Q. (2013). Tumour vasculogenic mimicry is associated with poor prognosis of human cancer patients: a systemic review and meta-analysis. European Journal of Cancer (Oxford, England: 1990), 49(18), 3914\u20133923. https:\/\/doi.org\/10.1016\/j.ejca.2013.07.148","DOI":"10.1016\/j.ejca.2013.07.148"},{"issue":"2","key":"10067_CR44","first-page":"560","volume":"62","author":"K Shirakawa","year":"2002","unstructured":"Shirakawa, K., Kobayashi, H., Heike, Y., Kawamoto, S., Brechbiel, M. W., Kasumi, F., & Wakasugi, H. (2002). Hemodynamics in vasculogenic mimicry and angiogenesis of inflammatory breast cancer xenograft. Cancer Research, 62(2), 560\u2013566.","journal-title":"Cancer Research"},{"key":"10067_CR45","doi-asserted-by":"publisher","DOI":"10.3892\/or.2018.6374","author":"J Ding","year":"2018","unstructured":"Ding, J., Jia, X., Zuo, B., He, J., Yang, J., & He, Y. (2018). A novel monoclonal antibody targeting a novel epitope of VE-cadherin inhibits vasculogenic mimicry of lung cancer cells. Oncology Reports. https:\/\/doi.org\/10.3892\/or.2018.6374","journal-title":"Oncology Reports"},{"issue":"S1","key":"10067_CR46","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s12032-010-9706-x","volume":"28","author":"W Liu","year":"2011","unstructured":"Liu, W., Xu, G., Jia, W., Li, J., Ma, J., Chen, K., & Wang, X. (2011). Prognostic significance and mechanisms of patterned matrix vasculogenic mimicry in hepatocellular carcinoma. Medical Oncology, 28(S1), 228\u2013238. https:\/\/doi.org\/10.1007\/s12032-010-9706-x","journal-title":"Medical Oncology"},{"issue":"4","key":"10067_CR47","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1111\/IGC.0b013e3181a389e6","volume":"19","author":"H-S Tang","year":"2009","unstructured":"Tang, H.-S., Feng, Y.-J., & Yao, L.-Q. (2009). Angiogenesis, vasculogenesis, and vasculogenic mimicry in ovarian cancer. International Journal of Gynecological Cancer, 19(4), 605\u2013610. https:\/\/doi.org\/10.1111\/IGC.0b013e3181a389e6","journal-title":"International Journal of Gynecological Cancer"},{"key":"10067_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/2408645","volume":"2016","author":"Q Guo","year":"2016","unstructured":"Guo, Q., Yuan, Y., Jin, Z., Xu, T., Gao, Y., Wei, H., & Hua, B. (2016). Association between tumor vasculogenic mimicry and the poor prognosis of gastric cancer in China: An updated systematic review and meta-analysis. BioMed Research International, 2016, 1\u20138. https:\/\/doi.org\/10.1155\/2016\/2408645","journal-title":"BioMed Research International"},{"issue":"1A","key":"10067_CR49","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1586\/14737140.6.1.59","volume":"26","author":"A Fujimoto","year":"2006","unstructured":"Fujimoto, A., Onodera, H., Mori, A., Nagayama, S., Yonenaga, Y., & Tachibana, T. (2006). Tumour plasticity and extravascular circulation in ECV304 human bladder carcinoma cells. Anticancer Research, 26(1A), 59\u201369.","journal-title":"Anticancer Research"},{"issue":"9","key":"10067_CR50","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1111\/jcmm.12851","volume":"20","author":"Q Liu","year":"2016","unstructured":"Liu, Q., Qiao, L., Liang, N., Xie, J., Zhang, J., Deng, G., & Zhang, J. (2016). The relationship between vasculogenic mimicry and epithelial-mesenchymal transitions. Journal of Cellular and Molecular Medicine, 20(9), 1761\u20131769. https:\/\/doi.org\/10.1111\/jcmm.12851","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"10","key":"10067_CR51","doi-asserted-by":"publisher","first-page":"4508","DOI":"10.1093\/rheumatology\/keab022","volume":"60","author":"E Andreucci","year":"2021","unstructured":"Andreucci, E., Margheri, F., Peppicelli, S., Bianchini, F., Ruzzolini, J., Laurenzana, A., & Calorini, L. (2021). Glycolysis-derived acidic microenvironment as a driver of endothelial dysfunction in systemic sclerosis. Rheumatology, 60(10), 4508\u20134519. https:\/\/doi.org\/10.1093\/rheumatology\/keab022","journal-title":"Rheumatology"},{"issue":"4","key":"10067_CR52","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.tranon.2017.04.007","volume":"10","author":"K Angara","year":"2017","unstructured":"Angara, K., Borin, T. F., & Arbab, A. S. (2017). Vascular mimicry: A novel neovascularization mechanism driving anti-angiogenic therapy (AAT) resistance in glioblastoma. Translational Oncology, 10(4), 650\u2013660. https:\/\/doi.org\/10.1016\/j.tranon.2017.04.007","journal-title":"Translational Oncology"},{"key":"10067_CR53","doi-asserted-by":"publisher","unstructured":"Serova, M., Tijeras-Raballand, A., Santos, C. D., Martinet, M., Neuzillet, C., Lopez, A., de Gramont, A. (2016). Everolimus affects vasculogenic mimicry in renal carcinoma resistant to sunitinib. Oncotarget, 7(25), 38467\u201338486. https:\/\/doi.org\/10.18632\/oncotarget.9542","DOI":"10.18632\/oncotarget.9542"},{"issue":"4","key":"10067_CR54","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1080\/15384047.2017.1294288","volume":"18","author":"H Sun","year":"2017","unstructured":"Sun, H., Zhang, D., Yao, Z., Lin, X., Liu, J., Gu, Q., & Sun, S. (2017). Anti-angiogenic treatment promotes triple-negative breast cancer invasion via vasculogenic mimicry. Cancer Biology & Therapy, 18(4), 205\u2013213. https:\/\/doi.org\/10.1080\/15384047.2017.1294288","journal-title":"Cancer Biology & Therapy"},{"issue":"3","key":"10067_CR55","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s10456-014-9420-y","volume":"17","author":"NS Vasudev","year":"2014","unstructured":"Vasudev, N. S., & Reynolds, A. R. (2014). Anti-angiogenic therapy for cancer: Current progress, unresolved questions and future directions. Angiogenesis, 17(3), 471\u2013494. https:\/\/doi.org\/10.1007\/s10456-014-9420-y","journal-title":"Angiogenesis"},{"issue":"6","key":"10067_CR56","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.3892\/ijo.2013.1897","volume":"42","author":"X-S Lu","year":"2013","unstructured":"Lu, X.-S., Sun, W., Ge, C.-Y., Zhang, W.-Z., & Fan, Y.-Z. (2013). Contribution of the PI3K\/MMPs\/Ln-5\u03b32 and EphA2\/FAK\/Paxillin signaling pathways to tumor growth and vasculogenic mimicry of gallbladder carcinomas. International Journal of Oncology, 42(6), 2103\u20132115. https:\/\/doi.org\/10.3892\/ijo.2013.1897","journal-title":"International Journal of Oncology"},{"issue":"9","key":"10067_CR57","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.3390\/ijms17091489","volume":"17","author":"M Pinto","year":"2016","unstructured":"Pinto, M., Sotomayor, P., Carrasco-Avino, G., Corvalan, A., & Owen, G. (2016). Escaping antiangiogenic therapy: Strategies employed by cancer cells. International Journal of Molecular Sciences, 17(9), 1489. https:\/\/doi.org\/10.3390\/ijms17091489","journal-title":"International Journal of Molecular Sciences"},{"issue":"3","key":"10067_CR58","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s10863-007-9085-y","volume":"39","author":"RJ Gillies","year":"2007","unstructured":"Gillies, R. J., & Gatenby, R. A. (2007). Adaptive landscapes and emergent phenotypes: Why do cancers have high glycolysis? Journal of Bioenergetics and Biomembranes, 39(3), 251\u2013257. https:\/\/doi.org\/10.1007\/s10863-007-9085-y","journal-title":"Journal of Bioenergetics and Biomembranes"},{"issue":"1","key":"10067_CR59","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nrc2255","volume":"8","author":"RA Gatenby","year":"2008","unstructured":"Gatenby, R. A., & Gillies, R. J. (2008). A microenvironmental model of carcinogenesis. Nature Reviews Cancer, 8(1), 56\u201361. https:\/\/doi.org\/10.1038\/nrc2255","journal-title":"Nature Reviews Cancer"},{"issue":"9","key":"10067_CR60","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1007\/s00018-019-03351-7","volume":"77","author":"R Lugano","year":"2020","unstructured":"Lugano, R., Ramachandran, M., & Dimberg, A. (2020). Tumor angiogenesis: Causes, consequences, challenges and opportunities. Cellular and Molecular Life Sciences, 77(9), 1745\u20131770. https:\/\/doi.org\/10.1007\/s00018-019-03351-7","journal-title":"Cellular and Molecular Life Sciences"},{"key":"10067_CR61","doi-asserted-by":"publisher","unstructured":"Muz, B., de la Puente, P., Azab, F., & Azab, A. K. (2015). The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy. Hypoxia (Auckland, N.Z.), 3, 83\u201392. https:\/\/doi.org\/10.2147\/HP.S93413","DOI":"10.2147\/HP.S93413"},{"issue":"4","key":"10067_CR62","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/biomedicines5020034","volume":"5","author":"M Rajabi","year":"2017","unstructured":"Rajabi, M., & Mousa, S. (2017). The role of angiogenesis in cancer treatment. Biomedicines, 5(4), 34. https:\/\/doi.org\/10.3390\/biomedicines5020034","journal-title":"Biomedicines"},{"issue":"12","key":"10067_CR63","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1177\/1947601911423654","volume":"2","author":"BL Krock","year":"2011","unstructured":"Krock, B. L., Skuli, N., & Simon, M. C. (2011). Hypoxia-induced angiogenesis: Good and evil. Genes & Cancer, 2(12), 1117\u20131133. https:\/\/doi.org\/10.1177\/1947601911423654","journal-title":"Genes & Cancer"},{"key":"10067_CR64","doi-asserted-by":"publisher","unstructured":"Hashimoto, T., & Shibasaki, F. (2015). Hypoxia-inducible factor as an angiogenic master switch. Frontiers in Pediatrics, 3.\u00a0https:\/\/doi.org\/10.3389\/fped.2015.00033","DOI":"10.3389\/fped.2015.00033"},{"issue":"1","key":"10067_CR65","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.canlet.2013.12.001","volume":"346","author":"R-C Ji","year":"2014","unstructured":"Ji, R.-C. (2014). Hypoxia and lymphangiogenesis in tumor microenvironment and metastasis. Cancer Letters, 346(1), 6\u201316. https:\/\/doi.org\/10.1016\/j.canlet.2013.12.001","journal-title":"Cancer Letters"},{"issue":"28","key":"10067_CR66","doi-asserted-by":"publisher","first-page":"3751","DOI":"10.1038\/sj.onc.1204500","volume":"20","author":"Q Shi","year":"2001","unstructured":"Shi, Q., Le, X., Wang, B., Abbruzzese, J. L., Xiong, Q., He, Y., & Xie, K. (2001). Regulation of vascular endothelial growth factor expression by acidosis in human cancer cells. Oncogene, 20(28), 3751\u20133756. https:\/\/doi.org\/10.1038\/sj.onc.1204500","journal-title":"Oncogene"},{"issue":"5","key":"10067_CR67","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1002\/(SICI)1097-0215(19980302)75:5<706::AID-IJC8>3.0.CO;2-2","volume":"75","author":"PAE Scott","year":"1998","unstructured":"Scott, P. A. E., Gleadle, J. M., Bicknell, R., & Harris, A. L. (1998). Role of the hypoxia sensing system, acidity and reproductive hormones in the variability of vascular endothelial growth factor induction in human breast carcinoma cell lines. International Journal of Cancer, 75(5), 706\u2013712. https:\/\/doi.org\/10.1002\/(SICI)1097-0215(19980302)75:5%3c706::AID-IJC8%3e3.0.CO;2-2","journal-title":"International Journal of Cancer"},{"issue":"8","key":"10067_CR68","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s10585-013-9595-4","volume":"30","author":"S Peppicelli","year":"2013","unstructured":"Peppicelli, S., Bianchini, F., Contena, C., Tombaccini, D., & Calorini, L. (2013). Acidic pH via NF-\u03baB favours VEGF-C expression in human melanoma cells. Clinical & Experimental Metastasis, 30(8), 957\u2013967. https:\/\/doi.org\/10.1007\/s10585-013-9595-4","journal-title":"Clinical & Experimental Metastasis"},{"issue":"3","key":"10067_CR69","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/S0002-9440(10)61765-8","volume":"159","author":"M Skobe","year":"2001","unstructured":"Skobe, M., Hamberg, L. M., Hawighorst, T., Schirner, M., Wolf, G. L., Alitalo, K., & Detmar, M. (2001). Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma. The American Journal of Pathology, 159(3), 893\u2013903. https:\/\/doi.org\/10.1016\/S0002-9440(10)61765-8","journal-title":"The American Journal of Pathology"},{"issue":"2","key":"10067_CR70","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.yexcr.2016.06.006","volume":"345","author":"M Nakanishi","year":"2016","unstructured":"Nakanishi, M., Morita, Y., Hata, K., & Muragaki, Y. (2016). Acidic microenvironments induce lymphangiogenesis and IL-8 production via TRPV1 activation in human lymphatic endothelial cells. Experimental Cell Research, 345(2), 180\u2013189. https:\/\/doi.org\/10.1016\/j.yexcr.2016.06.006","journal-title":"Experimental Cell Research"},{"key":"10067_CR71","doi-asserted-by":"publisher","unstructured":"Faes, S., Uldry, E., Planche, A., Santoro, T., Pythoud, C., Demartines, N., & Dormond, O. (2016). Acidic pH reduces VEGF-mediated endothelial cell responses by downregulation of VEGFR-2; relevance for anti-angiogenic therapies. Oncotarget, 7(52), 86026\u201386038. https:\/\/doi.org\/10.18632\/oncotarget.13323","DOI":"10.18632\/oncotarget.13323"},{"issue":"4","key":"10067_CR72","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s10456-014-9434-5","volume":"17","author":"HA Mena","year":"2014","unstructured":"Mena, H. A., Lokajczyk, A., Dizier, B., Strier, S. E., Voto, L. S., Boisson-Vidal, C., & Negrotto, S. (2014). Acidic preconditioning improves the proangiogenic responses of endothelial colony forming cells. Angiogenesis, 17(4), 867\u2013879. https:\/\/doi.org\/10.1007\/s10456-014-9434-5","journal-title":"Angiogenesis"},{"issue":"1","key":"10067_CR73","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s13287-018-0872-7","volume":"9","author":"HA Mena","year":"2018","unstructured":"Mena, H. A., Zubiry, P. R., Dizier, B., Schattner, M., Boisson-Vidal, C., & Negrotto, S. (2018). Acidic preconditioning of endothelial colony-forming cells (ECFC) promote vasculogenesis under proinflammatory and high glucose conditions in vitro and in vivo. Stem Cell Research & Therapy, 9(1), 120. https:\/\/doi.org\/10.1186\/s13287-018-0872-7","journal-title":"Stem Cell Research & Therapy"},{"issue":"6","key":"10067_CR74","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/bcr2416","volume":"11","author":"E Tomaskovic-Crook","year":"2009","unstructured":"Tomaskovic-Crook, E., Thompson, E. W., & Thiery, J. P. (2009). Epithelial to mesenchymal transition and breast cancer. Breast Cancer Research, 11(6), 213. https:\/\/doi.org\/10.1186\/bcr2416","journal-title":"Breast Cancer Research"},{"issue":"4","key":"10067_CR75","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrc2620","volume":"9","author":"K Polyak","year":"2009","unstructured":"Polyak, K., & Weinberg, R. A. (2009). Transitions between epithelial and mesenchymal states: Acquisition of malignant and stem cell traits. Nature Reviews Cancer, 9(4), 265\u2013273. https:\/\/doi.org\/10.1038\/nrc2620","journal-title":"Nature Reviews Cancer"},{"issue":"1","key":"10067_CR76","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1172\/JCI40027","volume":"120","author":"KMA Rouschop","year":"2010","unstructured":"Rouschop, K. M. A., van den Beucken, T., Dubois, L., Niessen, H., Bussink, J., Savelkouls, K., & Wouters, B. G. (2010). The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5. Journal of Clinical Investigation, 120(1), 127\u2013141. https:\/\/doi.org\/10.1172\/JCI40027","journal-title":"Journal of Clinical Investigation"},{"issue":"16","key":"10067_CR77","doi-asserted-by":"publisher","first-page":"3938","DOI":"10.1158\/0008-5472.CAN-11-3881","volume":"72","author":"JW Wojtkowiak","year":"2012","unstructured":"Wojtkowiak, J. W., Rothberg, J. M., Kumar, V., Schramm, K. J., Haller, E., Proemsey, J. B., & Gillies, R. J. (2012). Chronic autophagy is a cellular adaptation to tumor acidic pH microenvironments. Cancer Research, 72(16), 3938\u20133947. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-3881","journal-title":"Cancer Research"},{"issue":"24","key":"10067_CR78","doi-asserted-by":"publisher","first-page":"10113","DOI":"10.1158\/0008-5472.CAN-08-1839","volume":"68","author":"N Rohwer","year":"2008","unstructured":"Rohwer, N., Welzel, M., Daskalow, K., Pfander, D., Wiedenmann, B., Detjen, K., & Cramer, T. (2008). Hypoxia-inducible factor 1\u03b1 mediates anoikis resistance via suppression of \u03b15 integrin. Cancer Research, 68(24), 10113\u201310120. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-1839","journal-title":"Cancer Research"},{"key":"10067_CR79","doi-asserted-by":"publisher","first-page":"8340926","DOI":"10.1155\/2019\/8340926","volume":"2019","author":"S Peppicelli","year":"2019","unstructured":"Peppicelli, S., Ruzzolini, J., Bianchini, F., Andreucci, E., Nediani, C., Laurenzana, A., & Calorini, L. (2019). Anoikis resistance as a further trait of acidic-adapted melanoma cells. Journal of Oncology, 2019, 8340926. https:\/\/doi.org\/10.1155\/2019\/8340926","journal-title":"Journal of Oncology"},{"issue":"1","key":"10067_CR80","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12935-020-01719-5","volume":"21","author":"A Emami Nejad","year":"2021","unstructured":"Emami Nejad, A., Najafgholian, S., Rostami, A., Sistani, A., Shojaeifar, S., Esparvarinha, M., & Manian, M. (2021). The role of hypoxia in the tumor microenvironment and development of cancer stem cell: A novel approach to developing treatment. Cancer Cell International, 21(1), 62. https:\/\/doi.org\/10.1186\/s12935-020-01719-5","journal-title":"Cancer Cell International"},{"issue":"13","key":"10067_CR81","doi-asserted-by":"publisher","first-page":"4640","DOI":"10.1158\/0008-5472.CAN-10-3320","volume":"71","author":"J Mathieu","year":"2011","unstructured":"Mathieu, J., Zhang, Z., Zhou, W., Wang, A. J., Heddleston, J. M., Pinna, C. M. A., & Ruohola-Baker, H. (2011). HIF induces human embryonic stem cell markers in cancer cells. Cancer Research, 71(13), 4640\u20134652. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-3320","journal-title":"Cancer Research"},{"issue":"39","key":"10067_CR82","doi-asserted-by":"publisher","first-page":"16805","DOI":"10.1073\/pnas.0904606106","volume":"106","author":"A Pietras","year":"2009","unstructured":"Pietras, A., Hansford, L. M., Johnsson, A. S., Bridges, E., Sj\u00f6lund, J., Gisselsson, D., & P\u00e5hlman, S. (2009). HIF-2\u03b1 maintains an undifferentiated state in neural crest-like human neuroblastoma tumor-initiating cells. Proceedings of the National Academy of Sciences, 106(39), 16805\u201316810. https:\/\/doi.org\/10.1073\/pnas.0904606106","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"6","key":"10067_CR83","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ccr.2009.03.018","volume":"15","author":"Z Li","year":"2009","unstructured":"Li, Z., Bao, S., Wu, Q., Wang, H., Eyler, C., Sathornsumetee, S., & Rich, J. N. (2009). Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell, 15(6), 501\u2013513. https:\/\/doi.org\/10.1016\/j.ccr.2009.03.018","journal-title":"Cancer Cell"},{"issue":"4","key":"10067_CR84","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.3892\/or.2016.4997","volume":"36","author":"S Huang","year":"2016","unstructured":"Huang, S., Tang, Y., Peng, X., Cai, X., Wa, Q., Ren, D., & Huang, S. (2016). Acidic extracellular pH promotes prostate cancer bone metastasis by enhancing PC-3 stem cell characteristics, cell invasiveness and VEGF-induced vasculogenesis of BM-EPCs. Oncology Reports, 36(4), 2025\u20132032. https:\/\/doi.org\/10.3892\/or.2016.4997","journal-title":"Oncology Reports"},{"issue":"19","key":"10067_CR85","doi-asserted-by":"publisher","first-page":"5845","DOI":"10.1158\/0008-5472.CAN-15-2630","volume":"76","author":"A Filatova","year":"2016","unstructured":"Filatova, A., Seidel, S., B\u00f6\u011f\u00fcrc\u00fc, N., Gr\u00e4f, S., Garvalov, B. K., & Acker, T. (2016). Acidosis acts through HSP90 in a PHD\/VHL-independent manner to promote HIF function and stem cell maintenance in glioma. Cancer Research, 76(19), 5845\u20135856. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-2630","journal-title":"Cancer Research"},{"issue":"1","key":"10067_CR86","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41419-018-1242-1","volume":"10","author":"P Hu","year":"2019","unstructured":"Hu, P., Li, S., Tian, N., Wu, F., Hu, Y., Li, D., & Peng, X. (2019). Acidosis enhances the self-renewal and mitochondrial respiration of stem cell-like glioma cells through CYP24A1-mediated reduction of vitamin D. Cell Death & Disease, 10(1), 25. https:\/\/doi.org\/10.1038\/s41419-018-1242-1","journal-title":"Cell Death & Disease"},{"issue":"6","key":"10067_CR87","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1002\/ijc.30540","volume":"140","author":"S Avnet","year":"2017","unstructured":"Avnet, S., Di Pompo, G., Chano, T., Errani, C., Ibrahim-Hashim, A., Gillies, R. J., & Baldini, N. (2017). Cancer-associated mesenchymal stroma fosters the stemness of osteosarcoma cells in response to intratumoral acidosis via NF-\u03baB activation: Tumor acidic microenvironment fosters osteosarcoma stemness via mesenchymal stroma. International Journal of Cancer, 140(6), 1331\u20131345. https:\/\/doi.org\/10.1002\/ijc.30540","journal-title":"International Journal of Cancer"},{"key":"10067_CR88","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3389\/fonc.2018.00166","volume":"8","author":"N Zakaria","year":"2018","unstructured":"Zakaria, N., Mohd Yusoff, N., Zakaria, Z., Widera, D., & Yahaya, B. H. (2018). Inhibition of NF-\u03baB signaling reduces the stemness characteristics of lung cancer stem cells. Frontiers in Oncology, 8, 166. https:\/\/doi.org\/10.3389\/fonc.2018.00166","journal-title":"Frontiers in Oncology"},{"issue":"18","key":"10067_CR89","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1038\/onc.2012.252","volume":"32","author":"C Gong","year":"2013","unstructured":"Gong, C., Bauvy, C., Tonelli, G., Yue, W., Delom\u00e9nie, C., Nicolas, V., & Mehrpour, M. (2013). Beclin 1 and autophagy are required for the tumorigenicity of breast cancer stem-like\/progenitor cells. Oncogene, 32(18), 2261\u20132272. https:\/\/doi.org\/10.1038\/onc.2012.252","journal-title":"Oncogene"},{"issue":"2\u20133","key":"10067_CR90","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s10555-014-9506-4","volume":"33","author":"S Peppicelli","year":"2014","unstructured":"Peppicelli, S., Bianchini, F., & Calorini, L. (2014). Extracellular acidity, a \u201creappreciated\u201d trait of tumor environment driving malignancy: Perspectives in diagnosis and therapy. Cancer and Metastasis Reviews, 33(2\u20133), 823\u2013832. https:\/\/doi.org\/10.1007\/s10555-014-9506-4","journal-title":"Cancer and Metastasis Reviews"},{"issue":"1","key":"10067_CR91","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrc704","volume":"2","author":"AL Harris","year":"2002","unstructured":"Harris, A. L. (2002). Hypoxia \u2014 a key regulatory factor in tumour growth. Nature Reviews Cancer, 2(1), 38\u201347. https:\/\/doi.org\/10.1038\/nrc704","journal-title":"Nature Reviews Cancer"},{"issue":"3","key":"10067_CR92","doi-asserted-by":"publisher","first-page":"101017","DOI":"10.1016\/j.tranon.2021.101017","volume":"14","author":"VL Codony","year":"2021","unstructured":"Codony, V. L., & Tavassoli, M. (2021). Hypoxia-induced therapy resistance: Available hypoxia-targeting strategies and current advances in head and neck cancer. Translational Oncology, 14(3), 101017. https:\/\/doi.org\/10.1016\/j.tranon.2021.101017","journal-title":"Translational Oncology"},{"issue":"2","key":"10067_CR93","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1593\/neo.05697","volume":"8","author":"O Thews","year":"2006","unstructured":"Thews, O., Gassner, B., Kelleher, D. K., Schwerd, G., & Gekle, M. (2006). Impact of extracellular acidity on the activity of P-glycoprotein and the cytotoxicity of chemotherapeutic drugs. Neoplasia, 8(2), 143\u2013152. https:\/\/doi.org\/10.1593\/neo.05697","journal-title":"Neoplasia"},{"issue":"7","key":"10067_CR94","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/S0006-2952(03)00467-2","volume":"66","author":"BP Mahoney","year":"2003","unstructured":"Mahoney, B. P., Raghunand, N., Baggett, B., & Gillies, R. J. (2003). Tumor acidity, ion trapping and chemotherapeutics. Biochemical Pharmacology, 66(7), 1207\u20131218. https:\/\/doi.org\/10.1016\/S0006-2952(03)00467-2","journal-title":"Biochemical Pharmacology"},{"issue":"5","key":"10067_CR95","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1158\/1535-7163.MCT-06-0024","volume":"5","author":"LE Gerweck","year":"2006","unstructured":"Gerweck, L. E., Vijayappa, S., & Kozin, S. (2006). Tumor pH controls the in vivo efficacy of weak acid and base chemotherapeutics. Molecular Cancer Therapeutics, 5(5), 1275\u20131279. https:\/\/doi.org\/10.1158\/1535-7163.MCT-06-0024","journal-title":"Molecular Cancer Therapeutics"},{"issue":"7","key":"10067_CR96","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/sj.bjc.6690455","volume":"80","author":"N Raghunand","year":"1999","unstructured":"Raghunand, N., He, X., van Sluis, R., Mahoney, B., Baggett, B., Taylor, C. W., & Gillies, R. J. (1999). Enhancement of chemotherapy by manipulation of tumour pH. British Journal of Cancer, 80(7), 1005\u20131011. https:\/\/doi.org\/10.1038\/sj.bjc.6690455","journal-title":"British Journal of Cancer"},{"issue":"3","key":"10067_CR97","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/path.3994","volume":"227","author":"V Rausch","year":"2012","unstructured":"Rausch, V., Liu, L., Apel, A., Rettig, T., Gladkich, J., Labsch, S., & Herr, I. (2012). Autophagy mediates survival of pancreatic tumour-initiating cells in a hypoxic microenvironment: Autophagy in pancreatic tumourigenic cells. The Journal of Pathology, 227(3), 325\u2013335. https:\/\/doi.org\/10.1002\/path.3994","journal-title":"The Journal of Pathology"},{"issue":"2","key":"10067_CR98","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1172\/JCI28833","volume":"117","author":"RK Amaravadi","year":"2007","unstructured":"Amaravadi, R. K., Yu, D., Lum, J. J., Bui, T., Christophorou, M. A., Evan, G. I., & Thompson, C. B. (2007). Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. Journal of Clinical Investigation, 117(2), 326\u2013336. https:\/\/doi.org\/10.1172\/JCI28833","journal-title":"Journal of Clinical Investigation"},{"issue":"3","key":"10067_CR99","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/ijc.24402","volume":"125","author":"SL Lomonaco","year":"2009","unstructured":"Lomonaco, S. L., Finniss, S., Xiang, C., DeCarvalho, A., Umansky, F., Kalkanis, S. N., & Brodie, C. (2009). The induction of autophagy by \u03b3-radiation contributes to the radioresistance of glioma stem cells. International Journal of Cancer, 125(3), 717\u2013722. https:\/\/doi.org\/10.1002\/ijc.24402","journal-title":"International Journal of Cancer"},{"key":"10067_CR100","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3389\/fcell.2018.00104","volume":"6","author":"I Daskalaki","year":"2018","unstructured":"Daskalaki, I., Gkikas, I., & Tavernarakis, N. (2018). Hypoxia and selective autophagy in cancer development and therapy. Frontiers in Cell and Developmental Biology, 6, 104. https:\/\/doi.org\/10.3389\/fcell.2018.00104","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"10","key":"10067_CR101","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1128\/MCB.00166-09","volume":"29","author":"G Bellot","year":"2009","unstructured":"Bellot, G., Garcia-Medina, R., Gounon, P., Chiche, J., Roux, D., Pouyss\u00e9gur, J., & Mazure, N. M. (2009). Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains. Molecular and Cellular Biology, 29(10), 2570\u20132581. https:\/\/doi.org\/10.1128\/MCB.00166-09","journal-title":"Molecular and Cellular Biology"},{"issue":"10","key":"10067_CR102","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.1038\/cddis.2010.67","volume":"1","author":"ML Marino","year":"2010","unstructured":"Marino, M. L., Fais, S., Djavaheri-Mergny, M., Villa, A., Meschini, S., Lozupone, F., & De Milito, A. (2010). Proton pump inhibition induces autophagy as a survival mechanism following oxidative stress in human melanoma cells. Cell Death & Disease, 1(10), e87\u2013e87. https:\/\/doi.org\/10.1038\/cddis.2010.67","journal-title":"Cell Death & Disease"},{"issue":"11","key":"10067_CR103","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.4161\/auto.21501","volume":"8","author":"JW Wojtkowiak","year":"2012","unstructured":"Wojtkowiak, J. W., & Gillies, R. J. (2012). Autophagy on acid. Autophagy, 8(11), 1688\u20131689. https:\/\/doi.org\/10.4161\/auto.21501","journal-title":"Autophagy"},{"key":"10067_CR104","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.semcancer.2020.01.003","volume":"65","author":"R Abou Khouzam","year":"2020","unstructured":"Abou Khouzam, R., Goutham, H. V., Zaarour, R. F., Chamseddine, A. N., Francis, A., Buart, S., & Chouaib, S. (2020). Integrating tumor hypoxic stress in novel and more adaptable strategies for cancer immunotherapy. Seminars in Cancer Biology, 65, 140\u2013154. https:\/\/doi.org\/10.1016\/j.semcancer.2020.01.003","journal-title":"Seminars in Cancer Biology"},{"issue":"21","key":"10067_CR105","doi-asserted-by":"publisher","first-page":"8363","DOI":"10.3390\/ijms21218363","volume":"21","author":"JX Wang","year":"2020","unstructured":"Wang, J. X., Choi, S. Y. C., Niu, X., Kang, N., Xue, H., Killam, J., & Wang, Y. (2020). Lactic acid and an acidic tumor microenvironment suppress anticancer immunity. International Journal of Molecular Sciences, 21(21), 8363. https:\/\/doi.org\/10.3390\/ijms21218363","journal-title":"International Journal of Molecular Sciences"},{"issue":"3","key":"10067_CR106","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/imm.12917","volume":"154","author":"S Damgaci","year":"2018","unstructured":"Damgaci, S., Ibrahim-Hashim, A., Enriquez-Navas, P. M., Pilon-Thomas, S., Guvenis, A., & Gillies, R. J. (2018). Hypoxia and acidosis: Immune suppressors and therapeutic targets. Immunology, 154(3), 354\u2013362. https:\/\/doi.org\/10.1111\/imm.12917","journal-title":"Immunology"},{"key":"10067_CR107","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.semcancer.2017.03.001","volume":"43","author":"V Huber","year":"2017","unstructured":"Huber, V., Camisaschi, C., Berzi, A., Ferro, S., Lugini, L., Triulzi, T., & Rivoltini, L. (2017). Cancer acidity: An ultimate frontier of tumor immune escape and a novel target of immunomodulation. Seminars in Cancer Biology, 43, 74\u201389. https:\/\/doi.org\/10.1016\/j.semcancer.2017.03.001","journal-title":"Seminars in Cancer Biology"},{"key":"10067_CR108","doi-asserted-by":"publisher","unstructured":"Noman, M. Z., Hasmim, M., Messai, Y., Terry, S., Kieda, C., Janji, B., & Chouaib, S. (2015). Hypoxia: a key player in antitumor immune response. A review in the theme: cellular responses to hypoxia. American Journal of Physiology-Cell Physiology, 309(9), C569\u2013C579. https:\/\/doi.org\/10.1152\/ajpcell.00207.2015","DOI":"10.1152\/ajpcell.00207.2015"},{"key":"10067_CR109","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/2084195","volume":"2019","author":"RG Feichtinger","year":"2019","unstructured":"Feichtinger, R. G., & Lang, R. (2019). Targeting L-lactate metabolism to overcome resistance to immune therapy of melanoma and other tumor entities. Journal of Oncology, 2019, 1\u201312. https:\/\/doi.org\/10.1155\/2019\/2084195","journal-title":"Journal of Oncology"},{"key":"10067_CR110","doi-asserted-by":"publisher","first-page":"e11306","DOI":"10.7717\/peerj.11306","volume":"9","author":"M Hu","year":"2021","unstructured":"Hu, M., Li, Y., Lu, Y., Wang, M., Li, Y., Wang, C., & Zhao, H. (2021). The regulation of immune checkpoints by the hypoxic tumor microenvironment. Peer J, 9, e11306. https:\/\/doi.org\/10.7717\/peerj.11306","journal-title":"Peer J"},{"issue":"22","key":"10067_CR111","doi-asserted-by":"publisher","first-page":"6921","DOI":"10.1158\/0008-5472.CAN-11-1457","volume":"71","author":"F Hirschhaeuser","year":"2011","unstructured":"Hirschhaeuser, F., Sattler, U. G. A., & Mueller-Klieser, W. (2011). Lactate: A metabolic key player in cancer. Cancer Research, 71(22), 6921\u20136925. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-1457","journal-title":"Cancer Research"},{"issue":"11","key":"10067_CR112","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1158\/0008-5472.CAN-11-1272","volume":"72","author":"A Calcinotto","year":"2012","unstructured":"Calcinotto, A., Filipazzi, P., Grioni, M., Iero, M., De Milito, A., Ricupito, A., & Rivoltini, L. (2012). Modulation of microenvironment acidity reverses anergy in human and murine tumor-infiltrating T lymphocytes. Cancer Research, 72(11), 2746\u20132756. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-1272","journal-title":"Cancer Research"},{"issue":"1","key":"10067_CR113","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/cmi.2009.105","volume":"7","author":"J Sun","year":"2010","unstructured":"Sun, J., Zhang, Y., Yang, M., Zhang, Y., Xie, Q., Li, Z., & Qu, X. (2010). Hypoxia induces T-cell apoptosis by inhibiting chemokine C receptor 7 expression: The role of adenosine receptor A2. Cellular & Molecular Immunology, 7(1), 77\u201382. https:\/\/doi.org\/10.1038\/cmi.2009.105","journal-title":"Cellular & Molecular Immunology"},{"issue":"11","key":"10067_CR114","doi-asserted-by":"publisher","first-page":"4547","DOI":"10.1073\/pnas.0611732104","volume":"104","author":"KR Atkuri","year":"2007","unstructured":"Atkuri, K. R., Herzenberg, L. A., Niemi, A.-K., Cowan, T., & Herzenberg, L. A. (2007). Importance of culturing primary lymphocytes at physiological oxygen levels. Proceedings of the National Academy of Sciences, 104(11), 4547\u20134552. https:\/\/doi.org\/10.1073\/pnas.0611732104","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10067_CR115","doi-asserted-by":"publisher","unstructured":"Lukashev, D., Klebanov, B., Kojima, H., Grinberg, A., Ohta, A., Berenfeld, L., Sitkovsky, M. (2006). Cutting edge: hypoxia-inducible factor 1\u03b1 and its activation-inducible short isoform I.1 negatively regulate functions of CD4+ and CD8+ T lymphocytes. The Journal of Immunology, 177(8), 4962\u20134965. https:\/\/doi.org\/10.4049\/jimmunol.177.8.4962","DOI":"10.4049\/jimmunol.177.8.4962"},{"issue":"2","key":"10067_CR116","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/mi.2015.67","volume":"9","author":"K Fl\u00fcck","year":"2016","unstructured":"Fl\u00fcck, K., Breves, G., Fandrey, J., & Winning, S. (2016). Hypoxia-inducible factor 1 in dendritic cells is crucial for the activation of protective regulatory T cells in murine colitis. Mucosal Immunology, 9(2), 379\u2013390. https:\/\/doi.org\/10.1038\/mi.2015.67","journal-title":"Mucosal Immunology"},{"issue":"5","key":"10067_CR117","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1182\/blood-2005-05-1795","volume":"107","author":"E Gottfried","year":"2006","unstructured":"Gottfried, E., Kunz-Schughart, L. A., Ebner, S., Mueller-Klieser, W., Hoves, S., Andreesen, R., & Kreutz, M. (2006). Tumor-derived lactic acid modulates dendritic cell activation and antigen expression. Blood, 107(5), 2013\u20132021. https:\/\/doi.org\/10.1182\/blood-2005-05-1795","journal-title":"Blood"},{"issue":"9","key":"10067_CR118","doi-asserted-by":"publisher","first-page":"3723","DOI":"10.1182\/blood-2008-02-142091","volume":"112","author":"A Mancino","year":"2008","unstructured":"Mancino, A., Schioppa, T., Larghi, P., Pasqualini, F., Nebuloni, M., Chen, I.-H., & Sica, A. (2008). Divergent effects of hypoxia on dendritic cell functions. Blood, 112(9), 3723\u20133734. https:\/\/doi.org\/10.1182\/blood-2008-02-142091","journal-title":"Blood"},{"issue":"5","key":"10067_CR119","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1159\/000217905","volume":"15","author":"T Severin","year":"1994","unstructured":"Severin, T., M\u00fcller, B., Giese, G., Uhl, B., Wolf, B., Hauschildt, S., & Kreutz, W. (1994). pH-Dependent LAK cell cytotoxicity. Tumor Biology, 15(5), 304\u2013310. https:\/\/doi.org\/10.1159\/000217905","journal-title":"Tumor Biology"},{"issue":"3","key":"10067_CR120","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/0165-2478(92)90052-P","volume":"32","author":"S Ishizaka","year":"1992","unstructured":"Ishizaka, S., Kimoto, M., & Tsujii, T. (1992). Defect in generation of LAK cell activity under oxygen-limited conditions. Immunology Letters, 32(3), 209\u2013214. https:\/\/doi.org\/10.1016\/0165-2478(92)90052-P","journal-title":"Immunology Letters"},{"issue":"8\u201312","key":"10067_CR121","doi-asserted-by":"publisher","first-page":"3576","DOI":"10.2741\/2336","volume":"12","author":"Y-P Liao","year":"2007","unstructured":"Liao, Y.-P. (2007). Modification of the tumor microenvironment to enhance immunity. Frontiers in Bioscience, 12(8\u201312), 3576. https:\/\/doi.org\/10.2741\/2336","journal-title":"Frontiers in Bioscience"},{"issue":"1","key":"10067_CR122","doi-asserted-by":"publisher","first-page":"e000246","DOI":"10.1136\/jitc-2019-000246","volume":"8","author":"K Solocinski","year":"2020","unstructured":"Solocinski, K., Padget, M. R., Fabian, K. P., Wolfson, B., Cecchi, F., Hembrough, T., & Hodge, J. W. (2020). Overcoming hypoxia-induced functional suppression of NK cells. Journal for ImmunoTherapy of Cancer, 8(1), e000246. https:\/\/doi.org\/10.1136\/jitc-2019-000246","journal-title":"Journal for ImmunoTherapy of Cancer"},{"issue":"7519","key":"10067_CR123","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature13490","volume":"513","author":"OR Colegio","year":"2014","unstructured":"Colegio, O. R., Chu, N.-Q., Szabo, A. L., Chu, T., Rhebergen, A. M., Jairam, V., & Medzhitov, R. (2014). Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature, 513(7519), 559\u2013563. https:\/\/doi.org\/10.1038\/nature13490","journal-title":"Nature"},{"key":"10067_CR124","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2019.10956","author":"X Ke","year":"2019","unstructured":"Ke, X., Chen, C., Song, Y., Cai, Q., Li, J., Tang, Y., & Liu, D. (2019). Hypoxia modifies the polarization of macrophages and their inflammatory microenvironment, and inhibits malignant behavior in cancer cells. Oncology Letters. https:\/\/doi.org\/10.3892\/ol.2019.10956","journal-title":"Oncology Letters"},{"issue":"4","key":"10067_CR125","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1189\/jlb.70.4.478","volume":"70","author":"M Crowther","year":"2001","unstructured":"Crowther, M., Brown, N. J., Bishop, E. T., & Lewis, C. E. (2001). Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors. Journal of Leukocyte Biology, 70(4), 478\u2013490.","journal-title":"Journal of Leukocyte Biology"},{"issue":"3","key":"10067_CR126","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.4049\/jimmunol.1202702","volume":"191","author":"Z Husain","year":"2013","unstructured":"Husain, Z., Huang, Y., Seth, P., & Sukhatme, V. P. (2013). Tumor-derived lactate modifies antitumor immune response: Effect on myeloid-derived suppressor cells and NK cells. The Journal of Immunology, 191(3), 1486\u20131495. https:\/\/doi.org\/10.4049\/jimmunol.1202702","journal-title":"The Journal of Immunology"},{"issue":"6","key":"10067_CR127","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1158\/0008-5472.CAN-15-1743","volume":"76","author":"S Pilon-Thomas","year":"2016","unstructured":"Pilon-Thomas, S., Kodumudi, K. N., El-Kenawi, A. E., Russell, S., Weber, A. M., Luddy, K., & Gillies, R. J. (2016). Neutralization of tumor acidity improves antitumor responses to immunotherapy. Cancer Research, 76(6), 1381\u20131390. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-1743","journal-title":"Cancer Research"},{"issue":"1","key":"10067_CR128","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.imlet.2010.09.002","volume":"134","author":"NK Vishvakarma","year":"2010","unstructured":"Vishvakarma, N. K., & Singh, S. M. (2010). Immunopotentiating effect of proton pump inhibitor pantoprazole in a lymphoma-bearing murine host: Implication in antitumor activation of tumor-associated macrophages. Immunology Letters, 134(1), 83\u201392. https:\/\/doi.org\/10.1016\/j.imlet.2010.09.002","journal-title":"Immunology Letters"},{"issue":"3","key":"10067_CR129","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41568-020-00320-2","volume":"21","author":"G Bergers","year":"2021","unstructured":"Bergers, G., & Fendt, S.-M. (2021). The metabolism of cancer cells during metastasis. Nature Reviews Cancer, 21(3), 162\u2013180. https:\/\/doi.org\/10.1038\/s41568-020-00320-2","journal-title":"Nature Reviews Cancer"},{"issue":"3","key":"10067_CR130","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.cmet.2006.02.002","volume":"3","author":"J Kim","year":"2006","unstructured":"Kim, J., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006). HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia. Cell Metabolism, 3(3), 177\u2013185. https:\/\/doi.org\/10.1016\/j.cmet.2006.02.002","journal-title":"Cell Metabolism"},{"issue":"51","key":"10067_CR131","doi-asserted-by":"publisher","first-page":"32529","DOI":"10.1074\/jbc.271.51.32529","volume":"271","author":"GL Semenza","year":"1996","unstructured":"Semenza, G. L., Jiang, B.-H., Leung, S. W., Passantino, R., Concordet, J.-P., Maire, P., & Giallongo, A. (1996). Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. Journal of Biological Chemistry, 271(51), 32529\u201332537. https:\/\/doi.org\/10.1074\/jbc.271.51.32529","journal-title":"Journal of Biological Chemistry"},{"key":"10067_CR132","doi-asserted-by":"publisher","unstructured":"Trojan, S. E., Piwowar, M., Ostrowska, B., Laidler, P., & Kocemba-Pilarczyk, K. A. (2018). Analysis of malignant melanoma cell lines exposed to hypoxia reveals the importance of PFKFB4 overexpression for disease progression. Anticancer Research, 38(12), 6745\u20136752. https:\/\/doi.org\/10.21873\/anticanres.13044","DOI":"10.21873\/anticanres.13044"},{"issue":"12","key":"10067_CR133","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.trecan.2016.10.016","volume":"2","author":"L Schito","year":"2016","unstructured":"Schito, L., & Semenza, G. L. (2016). Hypoxia-inducible factors: Master regulators of cancer progression. Trends in Cancer, 2(12), 758\u2013770. https:\/\/doi.org\/10.1016\/j.trecan.2016.10.016","journal-title":"Trends in Cancer"},{"issue":"2","key":"10067_CR134","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.cmet.2013.11.022","volume":"19","author":"RC Sun","year":"2014","unstructured":"Sun, R. C., & Denko, N. C. (2014). Hypoxic regulation of glutamine metabolism through HIF1 and SIAH2 supports lipid synthesis that is necessary for tumor growth. Cell Metabolism, 19(2), 285\u2013292. https:\/\/doi.org\/10.1016\/j.cmet.2013.11.022","journal-title":"Cell Metabolism"},{"key":"10067_CR135","doi-asserted-by":"publisher","unstructured":"Peppicelli, S., Toti, A., Giannoni, E., Bianchini, F., Margheri, F., Del Rosso, M., & Calorini, L. (2016). Metformin is also effective on lactic acidosis-exposed melanoma cells switched to oxidative phosphorylation. Cell Cycle (Georgetown, Tex.), 15(14), 1908\u20131918. https:\/\/doi.org\/10.1080\/15384101.2016.1191706","DOI":"10.1080\/15384101.2016.1191706"},{"issue":"1","key":"10067_CR136","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12964-018-0297-z","volume":"16","author":"E Andreucci","year":"2018","unstructured":"Andreucci, E., Pietrobono, S., Peppicelli, S., Ruzzolini, J., Bianchini, F., Biagioni, A., & Calorini, L. (2018). SOX2 as a novel contributor of oxidative metabolism in melanoma cells. Cell Communication and Signaling: CCS, 16(1), 87. https:\/\/doi.org\/10.1186\/s12964-018-0297-z","journal-title":"Cell Communication and Signaling: CCS"},{"issue":"3","key":"10067_CR137","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/j.1349-7006.2012.02206.x","volume":"103","author":"EA Mazzio","year":"2012","unstructured":"Mazzio, E. A., Boukli, N., Rivera, N., & Soliman, K. F. A. (2012). Pericellular pH homeostasis is a primary function of the Warburg effect: Inversion of metabolic systems to control lactate steady state in tumor cells. Cancer Science, 103(3), 422\u2013432. https:\/\/doi.org\/10.1111\/j.1349-7006.2012.02206.x","journal-title":"Cancer Science"},{"issue":"2","key":"10067_CR138","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.cmet.2016.07.003","volume":"24","author":"C Corbet","year":"2016","unstructured":"Corbet, C., Pinto, A., Martherus, R., Santiago de Jesus, J. P., Polet, F., & Feron, O. (2016). Acidosis drives the reprogramming of fatty acid metabolism in cancer cells through changes in mitochondrial and histone acetylation. Cell Metabolism, 24(2), 311\u2013323. https:\/\/doi.org\/10.1016\/j.cmet.2016.07.003","journal-title":"Cell Metabolism"},{"issue":"19","key":"10067_CR139","doi-asserted-by":"publisher","first-page":"5507","DOI":"10.1158\/0008-5472.CAN-14-0705","volume":"74","author":"C Corbet","year":"2014","unstructured":"Corbet, C., Draoui, N., Polet, F., Pinto, A., Drozak, X., Riant, O., & Feron, O. (2014). The SIRT1\/HIF2\u03b1 Axis drives reductive glutamine metabolism under chronic acidosis and alters tumor response to therapy. Cancer Research, 74(19), 5507\u20135519. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-0705","journal-title":"Cancer Research"},{"issue":"2","key":"10067_CR140","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1158\/0008-5472.CAN-11-2076","volume":"72","author":"X Tang","year":"2012","unstructured":"Tang, X., Lucas, J. E., Chen, J.L.-Y., LaMonte, G., Wu, J., Wang, M. C., & Chi, J.-T. (2012). Functional interaction between responses to lactic acidosis and hypoxia regulates genomic transcriptional outputs. Cancer Research, 72(2), 491\u2013502. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-2076","journal-title":"Cancer Research"},{"issue":"5","key":"10067_CR141","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.devcel.2013.08.020","volume":"26","author":"M Giannotta","year":"2013","unstructured":"Giannotta, M., Trani, M., & Dejana, E. (2013). VE-cadherin and endothelial adherens junctions: Active guardians of vascular integrity. Developmental Cell, 26(5), 441\u2013454. https:\/\/doi.org\/10.1016\/j.devcel.2013.08.020","journal-title":"Developmental Cell"},{"issue":"3","key":"10067_CR142","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/nrc2806","volume":"10","author":"EB Pasquale","year":"2010","unstructured":"Pasquale, E. B. (2010). Eph receptors and ephrins in cancer: Bidirectional signalling and beyond. Nature Reviews. Cancer, 10(3), 165\u2013180. https:\/\/doi.org\/10.1038\/nrc2806","journal-title":"Nature Reviews. Cancer"},{"issue":"4","key":"10067_CR143","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.ajpath.2012.07.013","volume":"181","author":"REB Seftor","year":"2012","unstructured":"Seftor, R. E. B., Hess, A. R., Seftor, E. A., Kirschmann, D. A., Hardy, K. M., Margaryan, N. V., & Hendrix, M. J. C. (2012). Tumor cell vasculogenic mimicry. The American Journal of Pathology, 181(4), 1115\u20131125. https:\/\/doi.org\/10.1016\/j.ajpath.2012.07.013","journal-title":"The American Journal of Pathology"},{"issue":"21","key":"10067_CR144","doi-asserted-by":"publisher","first-page":"9851","DOI":"10.1158\/0008-5472.CAN-05-2172","volume":"65","author":"AR Hess","year":"2005","unstructured":"Hess, A. R., Postovit, L.-M., Margaryan, N. V., Seftor, E. A., Schneider, G. B., Seftor, R. E. B., & Hendrix, M. J. C. (2005). Focal adhesion kinase promotes the aggressive melanoma phenotype. Cancer Research, 65(21), 9851\u20139860. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-2172","journal-title":"Cancer Research"},{"issue":"9","key":"10067_CR145","doi-asserted-by":"publisher","first-page":"873","DOI":"10.3727\/096504021X16273798026651","volume":"28","author":"E Andreucci","year":"2022","unstructured":"Andreucci, E., Laurenzana, A., Peppicelli, S., Biagioni, A., Margheri, F., Ruzzolini, J., & Calorini, L. (2022). uPAR Controls vasculogenic mimicry ability expressed by drug-resistant melanoma cells. Oncology Research, 28(9), 873\u2013884. https:\/\/doi.org\/10.3727\/096504021X16273798026651","journal-title":"Oncology Research"},{"issue":"1","key":"10067_CR146","doi-asserted-by":"publisher","first-page":"846","DOI":"10.3892\/ol.2019.10380","volume":"18","author":"W Cao","year":"2019","unstructured":"Cao, W., Xu, C., Li, X., & Yang, X. (2019). Twist1 promotes astrocytoma development by stimulating vasculogenic mimicry. Oncology Letters, 18(1), 846\u2013855. https:\/\/doi.org\/10.3892\/ol.2019.10380","journal-title":"Oncology Letters"},{"issue":"1","key":"10067_CR147","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1038\/s41598-017-02494-6","volume":"7","author":"J Sun","year":"2017","unstructured":"Sun, J., Sun, B., Sun, R., Zhu, D., Zhao, X., Zhang, Y., & Zhang, D. (2017). HMGA2 promotes vasculogenic mimicry and tumor aggressiveness by upregulating Twist1 in gastric carcinoma. Scientific Reports, 7(1), 2229. https:\/\/doi.org\/10.1038\/s41598-017-02494-6","journal-title":"Scientific Reports"},{"issue":"3","key":"10067_CR148","doi-asserted-by":"publisher","first-page":"783","DOI":"10.3892\/ijmm.2015.2293","volume":"36","author":"K Liu","year":"2015","unstructured":"Liu, K., Sun, B., Zhao, X., Wang, X., Li, Y., Qiu, Z., & Zhao, N. (2015). Hypoxia promotes vasculogenic mimicry formation by the Twist1-Bmi1 connection in hepatocellular carcinoma. International Journal of Molecular Medicine, 36(3), 783\u2013791. https:\/\/doi.org\/10.3892\/ijmm.2015.2293","journal-title":"International Journal of Molecular Medicine"},{"issue":"4","key":"10067_CR149","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1158\/0008-5472.CAN-10-1660","volume":"71","author":"NY Frank","year":"2011","unstructured":"Frank, N. Y., Schatton, T., Kim, S., Zhan, Q., Wilson, B. J., Ma, J., & Frank, M. H. (2011). VEGFR-1 Expressed by malignant melanoma-initiating cells is required for tumor growth. Cancer Research, 71(4), 1474\u20131485. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-1660","journal-title":"Cancer Research"},{"key":"10067_CR150","doi-asserted-by":"publisher","first-page":"998","DOI":"10.3389\/fonc.2019.00998","volume":"9","author":"L Ayala-Dom\u00ednguez","year":"2019","unstructured":"Ayala-Dom\u00ednguez, L., Olmedo-Nieva, L., Mu\u00f1oz-Bello, J. O., Contreras-Paredes, A., Manzo-Merino, J., Mart\u00ednez-Ram\u00edrez, I., & Lizano, M. (2019). Mechanisms of vasculogenic mimicry in ovarian cancer. Frontiers in Oncology, 9, 998. https:\/\/doi.org\/10.3389\/fonc.2019.00998","journal-title":"Frontiers in Oncology"},{"issue":"5","key":"10067_CR151","doi-asserted-by":"publisher","first-page":"758","DOI":"10.4161\/cbt.7.5.5765","volume":"7","author":"J-Y Wang","year":"2008","unstructured":"Wang, J.-Y., Sun, T., Zhao, X.-L., Zhang, S.-W., Zhang, D.-F., Gu, Q., & Sun, B.-C. (2008). Functional significance of VEGF-a in human ovarian carcinoma: Role in vasculogenic mimicry. Cancer Biology & Therapy, 7(5), 758\u2013766. https:\/\/doi.org\/10.4161\/cbt.7.5.5765","journal-title":"Cancer Biology & Therapy"},{"issue":"6","key":"10067_CR152","doi-asserted-by":"publisher","first-page":"R69","DOI":"10.1186\/bcr1626","volume":"8","author":"GD Basu","year":"2006","unstructured":"Basu, G. D., Liang, W. S., Stephan, D. A., Wegener, L. T., Conley, C. R., Pockaj, B. A., & Mukherjee, P. (2006). A novel role for cyclooxygenase-2 in regulating vascular channel formation by human breast cancer cells. Breast Cancer Research: BCR, 8(6), R69. https:\/\/doi.org\/10.1186\/bcr1626","journal-title":"Breast Cancer Research: BCR"},{"issue":"4","key":"10067_CR153","doi-asserted-by":"publisher","first-page":"R422","DOI":"10.1186\/bcr1019","volume":"7","author":"GD Basu","year":"2005","unstructured":"Basu, G. D., Pathangey, L. B., Tinder, T. L., Gendler, S. J., & Mukherjee, P. (2005). Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells. Breast Cancer Research: BCR, 7(4), R422-435. https:\/\/doi.org\/10.1186\/bcr1019","journal-title":"Breast Cancer Research: BCR"},{"issue":"3","key":"10067_CR154","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/nm0302-289","volume":"8","author":"R Pai","year":"2002","unstructured":"Pai, R., Soreghan, B., Szabo, I. L., Pavelka, M., Baatar, D., & Tarnawski, A. S. (2002). Prostaglandin E2 transactivates EGF receptor: A novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nature Medicine, 8(3), 289\u2013293. https:\/\/doi.org\/10.1038\/nm0302-289","journal-title":"Nature Medicine"},{"key":"10067_CR155","doi-asserted-by":"publisher","first-page":"107776","DOI":"10.1016\/j.intimp.2021.107776","volume":"96","author":"X Liu","year":"2021","unstructured":"Liu, X., Lv, Z., Zhou, S., Kan, S., Liu, X., Jing, P., & Xu, W. (2021). MTDH in macrophages promotes the vasculogenic mimicry via VEGFA-165\/Flt-1 signaling pathway in head and neck squamous cell carcinoma. International Immunopharmacology, 96, 107776. https:\/\/doi.org\/10.1016\/j.intimp.2021.107776","journal-title":"International Immunopharmacology"},{"issue":"4","key":"10067_CR156","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1177\/147323001003800409","volume":"38","author":"L Shi","year":"2010","unstructured":"Shi, L., Lei, D., Ma, C., Xu, F., Li, Y., Wang, Y., & Pan, X. L. (2010). Clinicopathological implications of tumour-associated macrophages and vascularization in sinonasal melanoma. The Journal of International Medical Research, 38(4), 1276\u20131286. https:\/\/doi.org\/10.1177\/147323001003800409","journal-title":"The Journal of International Medical Research"},{"issue":"3","key":"10067_CR157","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00109-012-0956-2","volume":"91","author":"F Spinella","year":"2013","unstructured":"Spinella, F., Caprara, V., Di Castro, V., Rosan\u00f2, L., Cianfrocca, R., Natali, P. G., & Bagnato, A. (2013). Endothelin-1 induces the transactivation of vascular endothelial growth factor receptor-3 and modulates cell migration and vasculogenic mimicry in melanoma cells. Journal of Molecular Medicine (Berlin, Germany), 91(3), 395\u2013405. https:\/\/doi.org\/10.1007\/s00109-012-0956-2","journal-title":"Journal of Molecular Medicine (Berlin, Germany)"},{"issue":"1","key":"10067_CR158","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1021\/bi951501d","volume":"35","author":"LC Petersen","year":"1996","unstructured":"Petersen, L. C., Sprecher, C. A., Foster, D. C., Blumberg, H., Hamamoto, T., & Kisiel, W. (1996). Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor. Biochemistry, 35(1), 266\u2013272. https:\/\/doi.org\/10.1021\/bi951501d","journal-title":"Biochemistry"},{"issue":"5","key":"10067_CR159","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1093\/oxfordjournals.jbchem.a124648","volume":"116","author":"Y Miyagi","year":"1994","unstructured":"Miyagi, Y., Koshikawa, N., Yasumitsu, H., Miyagi, E., Hirahara, F., Aoki, I., & Miyazaki, K. (1994). cDNA cloning and mRNA expression of a serine proteinase inhibitor secreted by cancer cells: Identification as placental protein 5 and tissue factor pathway inhibitor-2. Journal of Biochemistry, 116(5), 939\u2013942. https:\/\/doi.org\/10.1093\/oxfordjournals.jbchem.a124648","journal-title":"Journal of Biochemistry"},{"issue":"1","key":"10067_CR160","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1006\/abbi.1996.0484","volume":"335","author":"CN Rao","year":"1996","unstructured":"Rao, C. N., Reddy, P., Liu, Y., O\u2019Toole, E., Reeder, D., Foster, D. C., & Woodley, D. T. (1996). Extracellular matrix-associated serine protease inhibitors (Mr 33,000, 31,000, and 27,000) are single-gene products with differential glycosylation: CDNA cloning of the 33-kDa inhibitor reveals its identity to tissue factor pathway inhibitor-2. Archives of Biochemistry and Biophysics, 335(1), 82\u201392. https:\/\/doi.org\/10.1006\/abbi.1996.0484","journal-title":"Archives of Biochemistry and Biophysics"},{"issue":"17","key":"10067_CR161","first-page":"5381","volume":"63","author":"W Ruf","year":"2003","unstructured":"Ruf, W., Seftor, E. A., Petrovan, R. J., Weiss, R. M., Gruman, L. M., Margaryan, N. V., & Hendrix, M. J. C. (2003). Differential role of tissue factor pathway inhibitors 1 and 2 in melanoma vasculogenic mimicry. Cancer Research, 63(17), 5381\u20135389.","journal-title":"Cancer Research"},{"issue":"3","key":"10067_CR162","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.bbrc.2017.06.140","volume":"490","author":"M Zang","year":"2017","unstructured":"Zang, M., Hu, L., Zhang, B., Zhu, Z., Li, J., Zhu, Z., & Liu, B. (2017). Luteolin suppresses angiogenesis and vasculogenic mimicry formation through inhibiting Notch1-VEGF signaling in gastric cancer. Biochemical and Biophysical Research Communications, 490(3), 913\u2013919. https:\/\/doi.org\/10.1016\/j.bbrc.2017.06.140","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"3","key":"10067_CR163","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s10238-012-0190-9","volume":"13","author":"A Vartanian","year":"2013","unstructured":"Vartanian, A., Gatsina, G., Grigorieva, I., Solomko, E., Dombrovsky, V., Baryshnikov, A., & Stepanova, E. (2013). The involvement of Notch signaling in melanoma vasculogenic mimicry. Clinical and Experimental Medicine, 13(3), 201\u2013209. https:\/\/doi.org\/10.1007\/s10238-012-0190-9","journal-title":"Clinical and Experimental Medicine"},{"key":"10067_CR164","doi-asserted-by":"publisher","unstructured":"Cheng, R., Cai, X.-R., Ke, K., & Chen, Y.-L. (2017). Notch4 inhibition suppresses invasion and vasculogenic mimicry formation of hepatocellular carcinoma cells. Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban, 37(5), 719\u2013725. https:\/\/doi.org\/10.1007\/s11596-017-1794-9","DOI":"10.1007\/s11596-017-1794-9"},{"issue":"24","key":"10067_CR165","doi-asserted-by":"publisher","first-page":"10340","DOI":"10.1158\/0008-5472.CAN-10-0705","volume":"70","author":"KM Hardy","year":"2010","unstructured":"Hardy, K. M., Kirschmann, D. A., Seftor, E. A., Margaryan, N. V., Postovit, L.-M., Strizzi, L., & Hendrix, M. J. C. (2010). Regulation of the embryonic morphogen Nodal by Notch4 facilitates manifestation of the aggressive melanoma phenotype. Cancer Research, 70(24), 10340\u201310350. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-0705","journal-title":"Cancer Research"},{"issue":"8","key":"10067_CR166","doi-asserted-by":"publisher","first-page":"18564","DOI":"10.3390\/ijms160818564","volume":"16","author":"L Qi","year":"2015","unstructured":"Qi, L., Song, W., Liu, Z., Zhao, X., Cao, W., & Sun, B. (2015). Wnt3a Promotes the vasculogenic mimicry formation of colon cancer via Wnt\/\u03b2-catenin signaling. International Journal of Molecular Sciences, 16(8), 18564\u201318579. https:\/\/doi.org\/10.3390\/ijms160818564","journal-title":"International Journal of Molecular Sciences"},{"issue":"02","key":"10067_CR167","doi-asserted-by":"publisher","first-page":"286","DOI":"10.4149\/neo_2019_190414N329","volume":"67","author":"N Yao","year":"2020","unstructured":"Yao, N., Ren, K., Gu, X. J., Wu, S. J., Shi, X., Chang, Q., & Zhou, J. (2020). Identification of potential crucial genes associated with vasculogenic mimicry in human osteosarcoma based on gene expression profile. Neoplasma, 67(02), 286\u2013295. https:\/\/doi.org\/10.4149\/neo_2019_190414N329","journal-title":"Neoplasma"},{"issue":"1","key":"10067_CR168","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13046-020-01800-x","volume":"40","author":"W Xie","year":"2021","unstructured":"Xie, W., Zhao, H., Wang, F., Wang, Y., He, Y., Wang, T., & Huang, G. (2021). A novel humanized Frizzled-7-targeting antibody enhances antitumor effects of bevacizumab against triple-negative breast cancer via blocking Wnt\/\u03b2-catenin signaling pathway. Journal of Experimental & Clinical Cancer Research: CR, 40(1), 30. https:\/\/doi.org\/10.1186\/s13046-020-01800-x","journal-title":"Journal of Experimental & Clinical Cancer Research: CR"},{"issue":"11","key":"10067_CR169","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.3390\/cells10112904","volume":"10","author":"S-U Shin","year":"2021","unstructured":"Shin, S.-U., Cho, H.-M., Das, R., Gil-Henn, H., Ramakrishnan, S., Al Bayati, A., & Rosenblatt, J. D. (2021). Inhibition of vasculogenic mimicry and angiogenesis by an anti-EGFR IgG1-human endostatin-P125A fusion protein reduces triple negative breast cancer metastases. Cells, 10(11), 2904. https:\/\/doi.org\/10.3390\/cells10112904","journal-title":"Cells"},{"key":"10067_CR170","doi-asserted-by":"publisher","first-page":"714646","DOI":"10.3389\/fonc.2021.714646","volume":"11","author":"B Geng","year":"2021","unstructured":"Geng, B., Zhu, Y., Yuan, Y., Bai, J., Dou, Z., Sui, A., & Luo, W. (2021). Artesunate suppresses choroidal melanoma vasculogenic mimicry formation and angiogenesis via the Wnt\/CaMKII signaling axis. Frontiers in Oncology, 11, 714646. https:\/\/doi.org\/10.3389\/fonc.2021.714646","journal-title":"Frontiers in Oncology"},{"issue":"5","key":"10067_CR171","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.3892\/or.2014.3454","volume":"32","author":"M Huang","year":"2014","unstructured":"Huang, M., Ke, Y., Sun, X., Yu, L., Yang, Z., Zhang, Y., & Huang, S. (2014). Mammalian target of rapamycin signaling is involved in the vasculogenic mimicry of glioma via hypoxia-inducible factor-1\u03b1. Oncology Reports, 32(5), 1973\u20131980. https:\/\/doi.org\/10.3892\/or.2014.3454","journal-title":"Oncology Reports"},{"issue":"47","key":"10067_CR172","doi-asserted-by":"publisher","first-page":"17894","DOI":"10.3748\/wjg.v20.i47.17894","volume":"20","author":"N-N Tang","year":"2014","unstructured":"Tang, N.-N., Zhu, H., Zhang, H.-J., Zhang, W.-F., Jin, H.-L., Wang, L., & Shi, R.-H. (2014). HIF-1\u03b1 induces VE-cadherin expression and modulates vasculogenic mimicry in esophageal carcinoma cells. World Journal of Gastroenterology, 20(47), 17894\u201317904. https:\/\/doi.org\/10.3748\/wjg.v20.i47.17894","journal-title":"World Journal of Gastroenterology"},{"issue":"4","key":"10067_CR173","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.freeradbiomed.2011.05.042","volume":"51","author":"G Comito","year":"2011","unstructured":"Comito, G., Calvani, M., Giannoni, E., Bianchini, F., Calorini, L., Torre, E., & Chiarugi, P. (2011). HIF-1\u03b1 stabilization by mitochondrial ROS promotes Met-dependent invasive growth and vasculogenic mimicry in melanoma cells. Free Radical Biology and Medicine, 51(4), 893\u2013904. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2011.05.042","journal-title":"Free Radical Biology and Medicine"},{"issue":"4","key":"10067_CR174","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.ajpath.2012.07.013","volume":"181","author":"REB Seftor","year":"2012","unstructured":"Seftor, R. E. B., Hess, A. R., Seftor, E. A., Kirschmann, D. A., Hardy, K. M., Margaryan, N. V., & Hendrix, M. J. C. (2012). Tumor cell vasculogenic mimicry: From controversy to therapeutic promise. The American Journal of Pathology, 181(4), 1115\u20131125. https:\/\/doi.org\/10.1016\/j.ajpath.2012.07.013","journal-title":"The American Journal of Pathology"},{"issue":"5","key":"10067_CR175","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1007\/s12032-012-0245-5","volume":"29","author":"N Zhao","year":"2012","unstructured":"Zhao, N., Sun, B., Sun, T., Ma, Y., Zhao, X., Liu, Z., & Gu, Q. (2012). Hypoxia-induced vasculogenic mimicry formation via VE-cadherin regulation by Bcl-2. Medical Oncology (Northwood, London, England), 29(5), 3599\u20133607. https:\/\/doi.org\/10.1007\/s12032-012-0245-5","journal-title":"Medical Oncology (Northwood, London, England)"},{"issue":"7","key":"10067_CR176","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1093\/neuonc\/not029","volume":"15","author":"X-G Mao","year":"2013","unstructured":"Mao, X.-G., Xue, X.-Y., Wang, L., Zhang, X., Yan, M., Tu, Y.-Y., & Song, S.-J. (2013). CDH5 is specifically activated in glioblastoma stemlike cells and contributes to vasculogenic mimicry induced by hypoxia. Neuro-Oncology, 15(7), 865\u2013879. https:\/\/doi.org\/10.1093\/neuonc\/not029","journal-title":"Neuro-Oncology"},{"issue":"1","key":"10067_CR177","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13046-021-01926-6","volume":"40","author":"S D\u2019Aguanno","year":"2021","unstructured":"D\u2019Aguanno, S., Mallone, F., Marenco, M., Del Bufalo, D., & Moramarco, A. (2021). Hypoxia-dependent drivers of melanoma progression. Journal of Experimental & Clinical Cancer Research: CR, 40(1), 159. https:\/\/doi.org\/10.1186\/s13046-021-01926-6","journal-title":"Journal of Experimental & Clinical Cancer Research: CR"},{"key":"10067_CR178","doi-asserted-by":"publisher","unstructured":"Li, S., Meng, W., Guan, Z., Guo, Y., & Han, X. (2016). The hypoxia-related signaling pathways of vasculogenic mimicry in tumor treatment. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 80, 127\u2013135. https:\/\/doi.org\/10.1016\/j.biopha.2016.03.010","DOI":"10.1016\/j.biopha.2016.03.010"},{"issue":"5","key":"10067_CR179","first-page":"1138","volume":"63","author":"B Krishnamachary","year":"2003","unstructured":"Krishnamachary, B., Berg-Dixon, S., Kelly, B., Agani, F., Feldser, D., Ferreira, G., & Semenza, G. L. (2003). Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Research, 63(5), 1138\u20131143.","journal-title":"Cancer Research"},{"issue":"2","key":"10067_CR180","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.yexmp.2015.02.001","volume":"98","author":"Y Li","year":"2015","unstructured":"Li, Y., Sun, B., Zhao, X., Zhang, D., Wang, X., Zhu, D., & Ban, X. (2015). Subpopulations of uPAR+ contribute to vasculogenic mimicry and metastasis in large cell lung cancer. Experimental and Molecular Pathology, 98(2), 136\u2013144. https:\/\/doi.org\/10.1016\/j.yexmp.2015.02.001","journal-title":"Experimental and Molecular Pathology"},{"issue":"11","key":"10067_CR181","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1093\/carcin\/bgv141","volume":"36","author":"KB Bedal","year":"2015","unstructured":"Bedal, K. B., Gr\u00e4ssel, S., Spanier, G., Reichert, T. E., & Bauer, R. J. (2015). The NC11 domain of human collagen XVI induces vasculogenic mimicry in oral squamous cell carcinoma cells. Carcinogenesis, 36(11), 1429\u20131439. https:\/\/doi.org\/10.1093\/carcin\/bgv141","journal-title":"Carcinogenesis"},{"issue":"1","key":"10067_CR182","doi-asserted-by":"publisher","first-page":"e0210399","DOI":"10.1371\/journal.pone.0210399","volume":"14","author":"E Hugdahl","year":"2019","unstructured":"Hugdahl, E., Bachmann, I. M., Schuster, C., Ladstein, R. G., & Akslen, L. A. (2019). Prognostic value of uPAR expression and angiogenesis in primary and metastatic melanoma. PLoS One, 14(1), e0210399. https:\/\/doi.org\/10.1371\/journal.pone.0210399","journal-title":"PLoS One"},{"issue":"8","key":"10067_CR183","doi-asserted-by":"publisher","first-page":"5759","DOI":"10.1007\/s13277-015-3762-y","volume":"36","author":"S Peppicelli","year":"2015","unstructured":"Peppicelli, S., Bianchini, F., & Calorini, L. (2015). Metabolic reprogramming as a continuous changing behavior of tumor cells. Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine, 36(8), 5759\u20135762. https:\/\/doi.org\/10.1007\/s13277-015-3762-y","journal-title":"Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine"},{"key":"10067_CR184","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.canlet.2017.08.010","volume":"408","author":"J Ruzzolini","year":"2017","unstructured":"Ruzzolini, J., Peppicelli, S., Andreucci, E., Bianchini, F., Margheri, F., Laurenzana, A., & Calorini, L. (2017). Everolimus selectively targets vemurafenib resistant BRAFV600E melanoma cells adapted to low pH. Cancer Letters, 408, 43\u201354. https:\/\/doi.org\/10.1016\/j.canlet.2017.08.010","journal-title":"Cancer Letters"},{"issue":"4","key":"10067_CR185","first-page":"693","volume":"16","author":"B Sun","year":"2006","unstructured":"Sun, B., Zhang, S., Zhang, D., Du, J., Guo, H., Zhao, X., & Hao, X. (2006). Vasculogenic mimicry is associated with high tumor grade, invasion and metastasis, and short survival in patients with hepatocellular carcinoma. Oncology Reports, 16(4), 693\u2013698.","journal-title":"Oncology Reports"},{"issue":"3","key":"10067_CR186","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s11060-013-1077-7","volume":"112","author":"S Wang","year":"2013","unstructured":"Wang, S., Ke, Y., Lu, G., Song, Z., Yu, L., Xiao, S., & Hu, C. (2013). Vasculogenic mimicry is a prognostic factor for postoperative survival in patients with glioblastoma. Journal of Neuro-Oncology, 112(3), 339\u2013345. https:\/\/doi.org\/10.1007\/s11060-013-1077-7","journal-title":"Journal of Neuro-Oncology"},{"key":"10067_CR187","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1186\/1471-2407-12-535","volume":"12","author":"S Wu","year":"2012","unstructured":"Wu, S., Yu, L., Wang, D., Zhou, L., Cheng, Z., Chai, D., & Tao, Y. (2012). Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry. BMC Cancer, 12, 535. https:\/\/doi.org\/10.1186\/1471-2407-12-535","journal-title":"BMC Cancer"},{"issue":"3","key":"10067_CR188","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.3390\/ijms23031321","volume":"23","author":"D-S Han","year":"2022","unstructured":"Han, D.-S., & Lee, E.-O. (2022). Sp1 plays a key role in vasculogenic mimicry of human prostate cancer cells. International Journal of Molecular Sciences, 23(3), 1321. https:\/\/doi.org\/10.3390\/ijms23031321","journal-title":"International Journal of Molecular Sciences"},{"key":"10067_CR189","doi-asserted-by":"publisher","unstructured":"Lezcano, C., Kleffel, S., Lee, N., Larson, A. R., Zhan, Q., DoRosario, A., Murphy, G. F. (2014). Merkel cell carcinoma expresses vasculogenic mimicry: demonstration in patients and experimental manipulation in xenografts. Laboratory Investigation; a Journal of Technical Methods and Pathology, 94(10), 1092\u20131102. https:\/\/doi.org\/10.1038\/labinvest.2014.99","DOI":"10.1038\/labinvest.2014.99"},{"issue":"8","key":"10067_CR190","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.3390\/cancers13081912","volume":"13","author":"D Belotti","year":"2021","unstructured":"Belotti, D., Pinessi, D., & Taraboletti, G. (2021). Alternative vascularization mechanisms in tumor resistance to therapy. Cancers, 13(8), 1912. https:\/\/doi.org\/10.3390\/cancers13081912","journal-title":"Cancers"},{"issue":"19","key":"10067_CR191","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1093\/jnci\/djh267","volume":"96","author":"DWJ van der Schaft","year":"2004","unstructured":"van der Schaft, D. W. J., Seftor, R. E. B., Seftor, E. A., Hess, A. R., Gruman, L. M., Kirschmann, D. A., & Hendrix, M. J. C. (2004). Effects of angiogenesis inhibitors on vascular network formation by human endothelial and melanoma cells. JNCI Journal of the National Cancer Institute, 96(19), 1473\u20131477. https:\/\/doi.org\/10.1093\/jnci\/djh267","journal-title":"JNCI Journal of the National Cancer Institute"},{"issue":"2","key":"10067_CR192","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3892\/or.2021.8242","volume":"47","author":"S Shimizu","year":"2021","unstructured":"Shimizu, S., Kawahara, R., & Simizu, S. (2021). Methionine aminopeptidase-2 is a pivotal regulator of vasculogenic mimicry. Oncology Reports, 47(2), 31. https:\/\/doi.org\/10.3892\/or.2021.8242","journal-title":"Oncology Reports"},{"key":"10067_CR193","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.canlet.2021.08.028","volume":"524","author":"M He","year":"2022","unstructured":"He, M., Yang, H., Shi, H., Hu, Y., Chang, C., Liu, S., & Yeh, S. (2022). Sunitinib increases the cancer stem cells and vasculogenic mimicry formation via modulating the lncRNA-ECVSR\/ER\u03b2\/Hif2-\u03b1 signaling. Cancer Letters, 524, 15\u201328. https:\/\/doi.org\/10.1016\/j.canlet.2021.08.028","journal-title":"Cancer Letters"},{"issue":"6","key":"10067_CR194","doi-asserted-by":"publisher","first-page":"E545","DOI":"10.1002\/ijc.29252","volume":"136","author":"F Ruffini","year":"2015","unstructured":"Ruffini, F., Graziani, G., Levati, L., Tentori, L., D\u2019Atri, S., & Lacal, P. M. (2015). Cilengitide downmodulates invasiveness and vasculogenic mimicry of neuropilin 1 expressing melanoma cells through the inhibition of \u03b1v\u03b25 integrin: Cilengitide inhibits melanoma invasiveness and vasculogenic mimicry. International Journal of Cancer, 136(6), E545\u2013E558. https:\/\/doi.org\/10.1002\/ijc.29252","journal-title":"International Journal of Cancer"},{"key":"10067_CR195","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.actbio.2019.06.039","volume":"94","author":"Y Wang","year":"2019","unstructured":"Wang, Y., Tong, L., Wang, J., Luo, J., Tang, J., Zhong, L., & Wang, Y. (2019). cRGD-functionalized nanoparticles for combination therapy of anti-endothelium dependent vessels and anti-vasculogenic mimicry to inhibit the proliferation of ovarian cancer. Acta Biomaterialia, 94, 495\u2013504. https:\/\/doi.org\/10.1016\/j.actbio.2019.06.039","journal-title":"Acta Biomaterialia"},{"issue":"1","key":"10067_CR196","doi-asserted-by":"publisher","first-page":"46659","DOI":"10.1038\/srep46659","volume":"7","author":"S Camorani","year":"2017","unstructured":"Camorani, S., Crescenzi, E., Gramanzini, M., Fedele, M., Zannetti, A., & Cerchia, L. (2017). Aptamer-mediated impairment of EGFR-integrin \u03b1v\u03b23 complex inhibits vasculogenic mimicry and growth of triple-negative breast cancers. Scientific Reports, 7(1), 46659. https:\/\/doi.org\/10.1038\/srep46659","journal-title":"Scientific Reports"},{"key":"10067_CR197","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.nano.2019.02.015","volume":"18","author":"F Bianchini","year":"2019","unstructured":"Bianchini, F., De Santis, A., Portioli, E., Russo Krauss, I., Battistini, L., Curti, C., & Sartori, A. (2019). Integrin-targeted AmpRGD sunitinib liposomes as integrated antiangiogenic tools. Nanomedicine: Nanotechnology Biology and Medicine, 18, 135\u2013145. https:\/\/doi.org\/10.1016\/j.nano.2019.02.015","journal-title":"Nanomedicine: Nanotechnology Biology and Medicine"},{"key":"10067_CR198","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.canlet.2018.12.021","volume":"446","author":"F Bianchini","year":"2019","unstructured":"Bianchini, F., Portioli, E., Ferlenghi, F., Vacondio, F., Andreucci, E., Biagioni, A., & Sartori, A. (2019). Cell-targeted c(AmpRGD)-sunitinib molecular conjugates impair tumor growth of melanoma. Cancer Letters, 446, 25\u201337. https:\/\/doi.org\/10.1016\/j.canlet.2018.12.021","journal-title":"Cancer Letters"},{"issue":"1","key":"10067_CR199","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1021\/acs.jmedchem.6b01266","volume":"60","author":"A Sartori","year":"2017","unstructured":"Sartori, A., Portioli, E., Battistini, L., Calorini, L., Pupi, A., Vacondio, F., & Zanardi, F. (2017). Synthesis of novel c(AmpRGD)-sunitinib dual conjugates as molecular tools targeting the \u03b1v\u03b23 integrin\/VEGFR2 couple and impairing tumor-associated angiogenesis. Journal of Medicinal Chemistry, 60(1), 248\u2013262. https:\/\/doi.org\/10.1021\/acs.jmedchem.6b01266","journal-title":"Journal of Medicinal Chemistry"},{"key":"10067_CR200","doi-asserted-by":"publisher","unstructured":"Liu, W., Lv, C., Zhang, B., Zhou, Q., & Cao, Z. (2017). MicroRNA-27b functions as a new inhibitor of ovarian cancer-mediated vasculogenic mimicry through suppression of VE-cadherin expression. RNA (New York, N.Y.), 23(7), 1019\u20131027. https:\/\/doi.org\/10.1261\/rna.059592.116","DOI":"10.1261\/rna.059592.116"},{"issue":"8","key":"10067_CR201","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/onc.2017.356","volume":"37","author":"EM Langer","year":"2018","unstructured":"Langer, E. M., Kendsersky, N. D., Daniel, C. J., Kuziel, G. M., Pelz, C., Murphy, K. M., & Sears, R. C. (2018). ZEB1-repressed microRNAs inhibit autocrine signaling that promotes vascular mimicry of breast cancer cells. Oncogene, 37(8), 1005\u20131019. https:\/\/doi.org\/10.1038\/onc.2017.356","journal-title":"Oncogene"},{"issue":"4","key":"10067_CR202","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/s41419-021-03682-z","volume":"12","author":"R Fu","year":"2021","unstructured":"Fu, R., Du, W., Ding, Z., Wang, Y., Li, Y., Zhu, J., & Huang, J. (2021). HIF-1\u03b1 promoted vasculogenic mimicry formation in lung adenocarcinoma through NRP1 upregulation in the hypoxic tumor microenvironment. Cell Death & Disease, 12(4), 394. https:\/\/doi.org\/10.1038\/s41419-021-03682-z","journal-title":"Cell Death & Disease"},{"key":"10067_CR203","doi-asserted-by":"publisher","first-page":"9288476","DOI":"10.1155\/2022\/9288476","volume":"2022","author":"B Wang","year":"2022","unstructured":"Wang, B., Zhang, H., Wei, L., & Li, Y. (2022). Expression of Dickkopf-1 and Twist2 in cervical squamous cell carcinoma and their correlation with vasculogenic mimicry. Journal of Healthcare Engineering, 2022, 9288476. https:\/\/doi.org\/10.1155\/2022\/9288476","journal-title":"Journal of Healthcare Engineering"},{"key":"10067_CR204","doi-asserted-by":"publisher","first-page":"107805","DOI":"10.1016\/j.pharmthera.2021.107805","volume":"223","author":"L Treps","year":"2021","unstructured":"Treps, L., Faure, S., & Clere, N. (2021). Vasculogenic mimicry, a complex and devious process favoring tumorigenesis \u2013 interest in making it a therapeutic target. Pharmacology & Therapeutics, 223, 107805. https:\/\/doi.org\/10.1016\/j.pharmthera.2021.107805","journal-title":"Pharmacology & Therapeutics"},{"issue":"5","key":"10067_CR205","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1002\/iub.2233","volume":"72","author":"S Haiaty","year":"2020","unstructured":"Haiaty, S., Rashidi, M.-R., Akbarzadeh, M., Maroufi, N. F., Yousefi, B., & Nouri, M. (2020). Targeting vasculogenic mimicry by phytochemicals: A potential opportunity for cancer therapy. IUBMB Life, 72(5), 825\u2013841. https:\/\/doi.org\/10.1002\/iub.2233","journal-title":"IUBMB Life"},{"issue":"4","key":"10067_CR206","first-page":"1857","volume":"34","author":"K Chiablaem","year":"2014","unstructured":"Chiablaem, K., Lirdprapamongkol, K., Keeratichamroen, S., Surarit, R., & Svasti, J. (2014). Curcumin suppresses vasculogenic mimicry capacity of hepatocellular carcinoma cells through STAT3 and PI3K\/AKT inhibition. Anticancer Research, 34(4), 1857\u20131864.","journal-title":"Anticancer Research"},{"issue":"3","key":"10067_CR207","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.3892\/ijo.2014.2500","volume":"45","author":"J-Q Guo","year":"2014","unstructured":"Guo, J.-Q., Zheng, Q.-H., Chen, H., Chen, L., Xu, J.-B., Chen, M.-Y., & Lin, S. (2014). Ginsenoside Rg3 inhibition of vasculogenic mimicry in pancreatic cancer through downregulation of VE-cadherin\/EphA2\/MMP9\/MMP2 expression. International Journal of Oncology, 45(3), 1065\u20131072. https:\/\/doi.org\/10.3892\/ijo.2014.2500","journal-title":"International Journal of Oncology"},{"issue":"2","key":"10067_CR208","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3892\/or.2017.6146","volume":"39","author":"X Li","year":"2018","unstructured":"Li, X., Yang, Z., Han, Z., Wen, Y., Ma, Z., & Wang, Y. (2018). Niclosamide acts as a new inhibitor of vasculogenic mimicry in oral cancer through upregulation of miR-124 and downregulation of STAT3. Oncology Reports, 39(2), 827\u2013833. https:\/\/doi.org\/10.3892\/or.2017.6146","journal-title":"Oncology Reports"},{"key":"10067_CR209","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.ejphar.2017.11.019","volume":"818","author":"H Han","year":"2018","unstructured":"Han, H., Du, L., Cao, Z., Zhang, B., & Zhou, Q. (2018). Triptonide potently suppresses pancreatic cancer cell-mediated vasculogenic mimicry by inhibiting expression of VE-cadherin and chemokine ligand 2 genes. European Journal of Pharmacology, 818, 593\u2013603. https:\/\/doi.org\/10.1016\/j.ejphar.2017.11.019","journal-title":"European Journal of Pharmacology"}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-022-10067-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10555-022-10067-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-022-10067-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T21:07:24Z","timestamp":1671224844000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10555-022-10067-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,13]]},"references-count":209,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["10067"],"URL":"https:\/\/doi.org\/10.1007\/s10555-022-10067-x","relation":{},"ISSN":["0167-7659","1573-7233"],"issn-type":[{"value":"0167-7659","type":"print"},{"value":"1573-7233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,13]]},"assertion":[{"value":"30 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}